Diabetes & Metabolism Journal

Original Articles

Drug/Regimen
Efficacy and Safety of Metformin and Atorvastatin Combination Therapy vs. Monotherapy with Either Drug in Type 2 Diabetes Mellitus and Dyslipidemia Patients (ATOMIC): Double-Blinded Randomized Controlled Trial: Jie-Eun Lee, Seung Hee Yu, Sung Rae Kim, Kyu Jeung Ahn, Kee-Ho Song, In-Kyu Lee, Ho-Sang Shon, In Joo Kim, Soo Lim, Doo-Man Kim, Choon Hee Chung, Won-Young Lee, Soon Hee Lee, Dong Joon Kim, Sung-Rae Cho, Chang Hee Jung, Hyun Jeong Jeon, Seung-Hwan Lee, Keun-Young Park, Sang Youl Rhee, Sin Gon Kim, Seok O Park, Dae Jung Kim, Byung Joon Kim, Sang Ah Lee, Yong-Hyun Kim, Kyung-Soo Kim, Ji A Seo, Il Seong Nam-Goong, Chang Won Lee, Duk Kyu Kim, Sang Wook Kim, Chung Gu Cho, Jung Han Kim, Yeo-Joo Kim, Jae-Myung Yoo, Kyung Wan Min, Moon-Kyu Lee; Diabetes Metab J. 2024;48(4):730-739. Published online May 20, 2024; DOI: https://doi.org/10.4093/dmj.2023.0077

33,043 View
745 Download
2 Web of Science
2 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
It is well known that a large number of patients with diabetes also have dyslipidemia, which significantly increases the risk of cardiovascular disease (CVD). This study aimed to evaluate the efficacy and safety of combination drugs consisting of metformin and atorvastatin, widely used as therapeutic agents for diabetes and dyslipidemia.
Methods
This randomized, double-blind, placebo-controlled, parallel-group and phase III multicenter study included adults with glycosylated hemoglobin (HbA1c) levels >7.0% and <10.0%, low-density lipoprotein cholesterol (LDL-C) >100 and <250 mg/dL. One hundred eighty-five eligible subjects were randomized to the combination group (metformin+atorvastatin), metformin group (metformin+atorvastatin placebo), and atorvastatin group (atorvastatin+metformin placebo). The primary efficacy endpoints were the percent changes in HbA1c and LDL-C levels from baseline at the end of the treatment.
Results
After 16 weeks of treatment compared to baseline, HbA1c showed a significant difference of 0.94% compared to the atorvastatin group in the combination group (0.35% vs. −0.58%, respectively; P<0.0001), whereas the proportion of patients with increased HbA1c was also 62% and 15%, respectively, showing a significant difference (P<0.001). The combination group also showed a significant decrease in LDL-C levels compared to the metformin group (−55.20% vs. −7.69%, P<0.001) without previously unknown adverse drug events.
Conclusion
The addition of atorvastatin to metformin improved HbA1c and LDL-C levels to a significant extent compared to metformin or atorvastatin alone in diabetes and dyslipidemia patients. This study also suggested metformin’s preventive effect on the glucose-elevating potential of atorvastatin in patients with type 2 diabetes mellitus and dyslipidemia, insufficiently controlled with exercise and diet. Metformin and atorvastatin combination might be an effective treatment in reducing the CVD risk in patients with both diabetes and dyslipidemia because of its lowering effect on LDL-C and glucose.

Citations

Citations to this article as recorded by

Real-world safety evaluation of atorvastatin: insights from the US FDA adverse event reporting system (FAERS)
Hongbing Wan, Xiuxiu Xu, Dasong Yi, Kexin Shuai
Expert Opinion on Drug Safety.2025; 24(3): 305. CrossRef
Exploration of metformin-based drug combination for mitigating diabetes-associated atherosclerotic diseases
Biao Qu, Zheng Li, Wei Hu
World Journal of Diabetes.2025;[Epub] CrossRef

Guideline/Fact Sheet
Dyslipidemia Fact Sheet in South Korea, 2022: Eun-Sun Jin, Jee-Seon Shim, Sung Eun Kim, Jae Hyun Bae, Shinae Kang, Jong Chul Won, Min-Jeong Shin, Heung Yong Jin, Jenny Moon, Hokyou Lee, Hyeon Chang Kim, In-Kyung Jeong, on Behalf of the Committee of Public Relation of the Korean Society of Lipid and Atherosclerosis; Diabetes Metab J. 2023;47(5):632-642. Published online August 2, 2023; DOI: https://doi.org/10.4093/dmj.2023.0135

21,398 View
580 Download
62 Web of Science
43 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
This study aimed to investigate the prevalence and status of dyslipidemia management among South Korean adults, as performed by the Korean Society of Lipid and Atherosclerosis under the name Dyslipidemia Fact Sheet 2022.
Methods
We analyzed the lipid profiles, age-standardized and crude prevalence, management status of hypercholesterolemia and dyslipidemia, and health behaviors among Korean adults aged ≥20 years, using the Korea National Health and Nutrition Examination Survey data between 2007 and 2020.
Results
In South Korea, the crude prevalence of hypercholesterolemia (total cholesterol ≥240 mg/dL or use of a lipid-lowering drug) in 2020 was 24%, and the age-standardized prevalence of hypercholesterolemia more than doubled from 2007 to 2020. The crude treatment rate was 55.2%, and the control rate was 47.7%. The crude prevalence of dyslipidemia—more than one out of three conditions (low-density lipoprotein cholesterol ≥160 or the use of a lipid-lowering drug, triglycerides ≥200, or high-density lipoprotein cholesterol [HDL-C] [men and women] <40 mg/dL)—was 40.2% between 2016 and 2020. However, it increased to 48.2% when the definition of hypo-HDL-cholesterolemia in women changed from <40 to <50 mg/dL.
Conclusion
Although the prevalence of hypercholesterolemia and dyslipidemia has steadily increased in South Korea, the treatment rate remains low. Therefore, continuous efforts are needed to manage dyslipidemia through cooperation between the national healthcare system, patients, and healthcare providers.

Citations

Citations to this article as recorded by

Nationwide Trends and Future Projections of Diabetes and Diabetic Retinopathy Prevalence in Korea: Korean National Health and Nutrition Examination Survey Study
Min Seok Kim, Seonghee Nam, Jeongwoo Lee, Se Joon Woo
Journal of Korean Medical Science.2026;[Epub] CrossRef
Novel metabolic syndrome subgroups and their association with cardiovascular outcomes: A data‐driven cluster analysis of the UK Biobank
Yongin Cho, Hye‐Sun Park, Dae Hyung Lee, Young Ju Suh, Jong Ho Jhee, Jong Hyun Jhee, So Hun Kim
Diabetes, Obesity and Metabolism.2026;[Epub] CrossRef
Muscle quality correlates with hearing thresholds: a cross-sectional analysis
Young-Jee Jeon, Ji Ho Lee, Byung Chul Kang, Joong Keun Kwon
Frontiers in Aging.2026;[Epub] CrossRef
Association Between Lipid-Lowering Drug Use and Sarcopenia: Analysis of the Korea National Health and Nutrition Examination Survey
Ah-Reum Shin, Keun-Gyu Park, Sung-Woo Kim
Journal of Lipid and Atherosclerosis.2026; 15(1): 151. CrossRef
Impaired insulin secretion via the Wnt5a/β-catenin pathway contributes to diabetes development in pancreatic cancer
Minyoung Lee, Ho Seon Park, Hyung Sun Kim, ARim Choi, Ji Hae Nahm, Beom Jin Lim, Jong Suk Park, Chul Woo Ahn, Younhee Ko, Dong Ki Lee, Dong Sup Yoon, Joon Seong Park, Shinae Kang
Experimental & Molecular Medicine.2026; 58(1): 272. CrossRef
Recent trends of low-density lipoprotein cholesterol control and lipid-lowering therapy in patients with atherosclerotic cardiovascular disease in Taiwan: 2015–2020
Tzu-Yang Chen, Yu-Chung Hsiao, Yen-Wen Wu, Tsung-Hsien Lin, Wayne Huey-Herng Sheu, Thung-Lip Lee, I-Chang Hsieh, Yi-Heng Li, Wei-Hsian Yin, Hung-I Yeh, Jaw-Wen Chen, Fang-Ju Lin, Chau-Chung Wu
Journal of the Formosan Medical Association.2025; 124(5): 419. CrossRef
Big Data Research for Diabetes-Related Diseases Using the Korean National Health Information Database
Kyung-Soo Kim, Bongseong Kim, Kyungdo Han
Diabetes & Metabolism Journal.2025; 49(1): 13. CrossRef
Automated process assessment of primary healthcare for hyperlipidemia: preliminary findings and implications form Anhui, China
Ningjing Yang, Yuning Wang, Ying Li, Dongying Xiao, Ruirui Cui, Nana Li, Rong Liu, Jing Chai, Xingrong Shen, Debin Wang
Lipids in Health and Disease.2025;[Epub] CrossRef
Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease
Jun Young Kim, Byung Soo Kwan, Jung Hwan Cho, Hye In Kim, Nak Gyeong Ko, Mihyeon Jin, Ok Jae Lee
Journal of Clinical Medicine.2025; 14(4): 1073. CrossRef
Older Adults with Diabetes in Korea: Latest Clinical and Epidemiologic Trends
Kyuho Kim, Bongseong Kim, Kyuna Lee, Yu-Bae Ahn, Seung-Hyun Ko, Sung Hee Choi, Kyungdo Han, Jae-Seung Yun
Diabetes & Metabolism Journal.2025; 49(2): 183. CrossRef
Comparing non-alcoholic fatty liver disease indices in predicting the prevalence and incidence of metabolic syndrome in middle-aged adults
Byung Sik Kim, Hyun-Jin Kim, Seong Won Jeon, Kyung Hwan Kim, Dong Wook Kim, Jeong-Hun Shin
Heliyon.2025; 11(7): e43073. CrossRef
Current Status of Development of Oral Formulations Combining Omega-3 Fatty Acids and Statin Ingredients and Prospects for New Formulations
Ji-Hun Jang, Seung-Hyun Jeong
Journal of Pharmaceutical Innovation.2025;[Epub] CrossRef
A Scoring Model Using Multi-Metabolites Based on Untargeted Metabolomics for Assessing Dyslipidemia in Korean Individuals with Obesity
Su-Geun Yang, Hye Jin Yoo
Metabolites.2025; 15(4): 279. CrossRef
Addressing Cardiovascular Diseases Challenges in South Korea: Strategies to Improve Outcomes
Hyun-Jae Kang, JuMee Wang, Eun Joo Cho, Hack- Lyoung Kim, Chan Joo Lee, Jae Hyoung Park, Jeehoon Kang, Jon Suh, Ki Hong Choi, Seung-Yul Lee, Jong-Il Choi, Il-young Oh, Ungjeong Do, Seung Young Roh, Sang-Ho Jo, Jin Wi, Dae-Hwan Bae, Mi-Hyang Jung, Chan Seo
Korean Circulation Journal.2025; 55(7): 557. CrossRef
Exposure to polycyclic aromatic hydrocarbons, heavy metals, and per- and polyfluoroalkyl substances and their associations with serum lipid profiles in the general Korean adult population
Sanghee Shin, Youlim Kim, Yunsoo Choe, Su Hwan Kim, Jaelim Cho, Changsoo Kim, Kyoung-Nam Kim
Environmental Health.2025;[Epub] CrossRef
Relative Grip Strength and Muscle-Strengthening Activity: Independent and Joint Associations with Type 2 Diabetes Mellitus
Yunmin Han, Yeon Soo Kim
Journal of Obesity & Metabolic Syndrome.2025; 34(2): 148. CrossRef
Comparative Effectiveness and Safety of Moderate-Intensity Pravastatin Versus Atorvastatin in Patients with Dyslipidemia: A Retrospective Cohort Study Using a Common Data Model of Multicenter Electronic Health Records in South Korea
Sung Wan Chun, Hae Jin Kim, Ji A Seo, Suk Chon, Sung Eun Kim, Jung Hwa Jung, Sang Soo Kim, Hyejin Lee, Sanghoon Shin, So Hun Kim, Dughyun Choi, Hyeong Kyu Park, Soo-Kyung Kim, Ji-Hwan Bae, In-Kyung Jeong
Journal of Atherosclerosis and Thrombosis.2025; 32(10): 1268. CrossRef
National trends in dyslipidemia prevalence, awareness, treatment, and control in South Korea from 2005 to 2022
Hyeseung Lee, Seokjun Kim, Yejun Son, Soeun Kim, Hyeon Jin Kim, Hyesu Jo, Jaeyu Park, Kyeongmin Lee, Hayeon Lee, Jiseung Kang, Selin Woo, Sunyoung Kim, Sang Youl Rhee, Jiyoung Hwang, Lee Smith, Dong Keon Yon
Scientific Reports.2025;[Epub] CrossRef
Sex‐ and age‐specific determinants of diabetes: Insights from BKMR and cox modelling of metabolic and lifestyle risk factors in a Korean cohort
Hye Ah Lee
Diabetes, Obesity and Metabolism.2025; 27(9): 5247. CrossRef
Efficacy and safety of lobeglitazone added to metformin and sitagliptin combination therapy in patients with type 2 diabetes: A 52‐week, multicentre, randomized, placebo‐controlled, phase III clinical trial
Eun‐Gyoung Hong, Kyung‐Wan Min, SungWan Chun, Choon Hee Chung, Seungjoon Oh, Chang Beom Lee, Dong‐Jun Kim, Hye Soon Kim, Ji Oh Mok, Tae Seo Sohn, Jeong Hyun Park, Sung Hee Choi, Sungrae Kim, Sang Soo Kim, Kyu Yeon Hur, Chong Hwa Kim, Young Min Cho, Byung‐
Diabetes, Obesity and Metabolism.2025; 27(10): 5727. CrossRef
The impact of sleep health on cardiovascular and all-cause mortality in the general population
Soo Jung Park, Jinsun Park, Byung Sik Kim, Jin-Kyu Park
Scientific Reports.2025;[Epub] CrossRef
Pharmacologic Potential of Statins in Cancer Prevention: Colo-Rectal Cancer Risk in Dyslipidemic Patients from a Korean Nationwide Cohort
Ho Suk Kang, Joo-Hee Kim, Heejin Kim, Joong Seob Lee, Hyo Geun Choi, Dae Myoung Yoo, Kyeong Min Han, Nan Young Kim, Kyueng-Whan Min, Mi Jung Kwon
Pharmaceuticals.2025; 18(8): 1236. CrossRef
A genome-wide study on gene–nutrient interactions for hyperuricemia in a large Korean cohort (KoGES)
Ehn-Young Kim, Ja-Eun Choi, Ji-Won Lee, Jae-Min Park, Youhyun Song, Yu-Jin Kwon, Kyung-Won Hong
Scientific Reports.2025;[Epub] CrossRef
Safety and Effectiveness of Pravastatin in Korean Patients with Dyslipidemia Based on the Cardiovascular Risk Classification: Pooled Analysis of Four Observational Studies
In-Kyung Jeong, Hyuk-Sang Kwon, Dae Jung Kim, Sin Gon Kim
Endocrinology and Metabolism.2025; 40(4): 598. CrossRef
Prevalence and Factors Associated with Dyslipidemia Among Older Adults in Korea
Do-Youn Lee
Journal of The Korean Society of Physical Medicine.2025; 20(3): 121. CrossRef
Associations of body mass index, waist circumference, and weight-adjusted waist index with body composition and biomarkers: a multinational pooled analysis
Jin Eui Kim, Dahyun Park, Dong Hoon Lee, Garam Jo, Madison Kindred, Jason Jaggers, Xuemei Sui, Ryan Porter, Chibueze Ogbonnaya, Mark Hamer, Vivek Prasad, Min-Jeong Shin, Edward Giovannucci, Hannah Oh
The American Journal of Clinical Nutrition.2025; 122(5): 1432. CrossRef
Risk of Sarcopenic Obesity Across Menopausal Transition Stages in Middle-Aged Korean Women
Yoosun Cho, Yoonyoung Jang, Jae Ho Park, Yoosoo Chang, Seungho Ryu
Nutrients.2025; 17(20): 3238. CrossRef
Trends in Prevalence of Obesity and Related Cardiometabolic and Renal Complications in Korea: A Nationwide Study 2007 to 2022
Eugene Han, Byung-Wan Lee, Eun Seok Kang, Bong-Soo Cha, Jangho Lee, Yong-ho Lee
Journal of Obesity & Metabolic Syndrome.2025; 34(4): 414. CrossRef
Present and Future of Cardiovascular Diseases in Korea: Prevention, Management, and Policy Recommendations
JuMee Wang, Hyun-Jae Kang, Eun Joo Cho, Jae Hyoung Park, Jon Suh, Jong-Il Choi, Sang-Ho Jo, Chan Seok Park, Jang-Whan Bae
The Korean Journal of Medicine.2025; 100(5): 201. CrossRef
Association of Elevated Serum Triglycerides with Colorectal Cancer Risk: Findings from a Large-scale Prospective Cohort of Korean Adults
Sukhong Min, Hyobin Lee, Sinyoung Cho, Seung-Yong Jeong, Aesun Shin, Daehee Kang
Cancer Prevention Research.2025; 18(11): 681. CrossRef
Causal effect of kimchi intake on HDL-cholesterol levels in middle aged Korean men: a two-sample Mendelian randomization analysis
Jaehee Cha, Seong-Hee Ko, Dayeon Shin
Genes & Nutrition.2025;[Epub] CrossRef
Ten-Year Weight Regain after Bariatric Surgery: Prevalence, Predictors, and Metabolic Impact
Sara Ribeiro, Patrícia Ferreira, Bruno Lima, Telma Moreno, Juliana Gonçalves, Helena Urbano Ferreira, Inês Meira, João Menino, Ana Rita Leite, Marta Borges-Canha, Maria Manuel Silva, Vanessa Guerreiro, Jorge Pedro, Ana Varela, Diana Festas Silva, Paula Fr
Obesity Facts.2025; : 1. CrossRef
Interactive effects of high-density lipoprotein cholesterol and insulin resistance on depression: results from the NHANES (2005–2018)
Liang Rao, Jing Li, Xiaohua Xian, Yanyi Hu, Yin Xian
Lipids in Health and Disease.2025;[Epub] CrossRef
Incidence and risk factors for idiopathic pulmonary fibrosis in individuals aged 75 years and older in an ultra-aging society
Bo-Guen Kim, Kyungdo Han, Ju-Yeong Park, Bongseong Kim, Dong-Woo Han, Sung Jun Chung, Hyung Koo Kang, Sang-Heon Kim, Moo Suk Park, Jang Won Sohn, Ho Joo Yoon, Hyun Lee
Therapeutic Advances in Respiratory Disease.2025;[Epub] CrossRef
Oxidative Balance Score and New-Onset Type 2 Diabetes Mellitus in Korean Adults without Non-Alcoholic Fatty Liver Disease: Korean Genome and Epidemiology Study-Health Examinees (KoGES-HEXA) Cohort
Mid-Eum Moon, Dong Hyuk Jung, Seok-Jae Heo, Byoungjin Park, Yong Jae Lee
Antioxidants.2024; 13(1): 107. CrossRef
Comparison of metabolic and neurological comorbidities in Asian patients with psoriasis and atopic dermatitis
Hee Joo Yang, Mi Young Lee, Jeong Hyeon Lee, Chang Jin Jung, Woo Jin Lee, Chong Hyun Won, Mi Woo Lee, Joon Min Jung, Sung Eun Chang
Scientific Reports.2024;[Epub] CrossRef
Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population
Rihwa Choi, Sang Gon Lee, Eun Hee Lee
Metabolites.2024; 14(3): 169. CrossRef
Body Weight Variability and Risk of Suicide Mortality: A Nationwide Population-Based Study
Jeongmin Lee, Jin-Hyung Jung, Dong Woo Kang, Min-Hee Kim, Dong-Jun Lim, Hyuk-Sang Kwon, Jung Min Lee, Sang-Ah Chang, Kyungdo Han, Seung-Hwan Lee, Fuquan Zhang
Depression and Anxiety.2024; 2024: 1. CrossRef
Association of atherosclerosis indices, serum uric acid to high‐density lipoprotein cholesterol ratio and triglycerides‐glucose index with hypertension: A gender‐disaggregated analysis
Rana Kolahi Ahari, Toktam Sahranavard, Amin Mansoori, Zahra Fallahi, Negin Babaeepoor, Gordon Ferns, Majid Ghayour‐Mobarhan
The Journal of Clinical Hypertension.2024; 26(6): 645. CrossRef
A Machine Learning Approach to Identify of Dyslipidemia based on Body Composition Indices in Men
Mi Hong Yim, Sanghun Lee
The Journal of Korean Institute of Information Technology.2024; 22(6): 153. CrossRef
Association of aerobic and muscle-strengthening physical activity with chronic kidney disease in participants with hypertension
Yunmin Han, Younghwan Choi, Yeon Soo Kim
Clinical Hypertension.2024;[Epub] CrossRef
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
Endocrinology and Metabolism.2024; 39(5): 722. CrossRef
Exploring Utilization and Establishing Reference Intervals for the Apolipoprotein B Test in the Korean Population
Rihwa Choi, Sang Gon Lee, Eun Hee Lee
Diagnostics.2023; 13(20): 3194. CrossRef

Review

Complications
Dyslipidemia in Patients with Chronic Kidney Disease: An Updated Overview: Sang Heon Suh, Soo Wan Kim; Diabetes Metab J. 2023;47(5):612-629. Published online July 24, 2023; DOI: https://doi.org/10.4093/dmj.2023.0067

30,139 View
1,477 Download
61 Web of Science
72 Crossref

Abstract PDF PubReader ePub

Dyslipidemia is a potentially modifiable cardiovascular risk factor. Whereas the recommendations for the treatment target of dyslipidemia in the general population are being more and more rigorous, the 2013 Kidney Disease: Improving Global Outcomes clinical practice guideline for lipid management in chronic kidney disease (CKD) presented a relatively conservative approach with respect to the indication of lipid lowering therapy and therapeutic monitoring among the patients with CKD. This may be largely attributed to the lack of high-quality evidence derived from CKD population, among whom the overall feature of dyslipidemia is considerably distinctive to that of general population. In this review article, we cover the characteristic features of dyslipidemia and impact of dyslipidemia on cardiovascular outcomes in patients with CKD. We also review the current evidence on lipid lowering therapy to modify the risk of cardiovascular events in this population. We finally discuss the association between dyslipidemia and CKD progression and the potential strategy to delay the progression of CKD in relation to lipid lowering therapy.

Citations

Citations to this article as recorded by

Therapeutic potential of S-nitroso-l-cysteine in improving cardiorenal function in eNOS-KO CKD mice
Xiaofan Wu, Jiahe Zhao, Zhengqi Xu, Feng Jiang, Moran Wang, Jingwen Tao, Cuntai Zhang, Li Lin, Sheng Li
Nitric Oxide.2026; 161: 9. CrossRef
Lipid-Lowering Therapies in Patients with Chronic Kidney Disease: A Perspective on High-Density Lipoprotein Cholesterol
Mohammad Abdullah Al Zubair Naim, Keiichi Sumida, Elani Streja, Fridtjof Thomas, Robert Lowell Davis, Kamyar Kalantar-Zadeh, Csaba P. Kovesdy
Drugs.2026; 86(2): 177. CrossRef
Dyslipidemia and lipid-lowering therapy in patients on renal replacement therapy: a literature review
A. V. Samburov, N. A. Khaibulina, T. L. Kulik, Sh. R. Galeev
Russian Journal of Transplantology and Artificial Organs.2026; 27(4): 158. CrossRef
Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review
Tatjana Ábel, Béla Benczúr, Éva Csobod Csajbókné
European Journal of Clinical Pharmacology.2026;[Epub] CrossRef
The predictive value of glycated albumin and hemoglobin A1c for all-cause and cardiovascular mortality in chronic kidney disease patients
Boshui Huang, Minglong Zheng, Jiaxu Li, Changchang Fang, Yifan Wu, Yao Xiao, Peng Yu, Wenli Gu, Shuxian Zhou, Yuling Zhang, Bo Liu, Xiao Liu, Zhaoyu Liu
Diabetology & Metabolic Syndrome.2026;[Epub] CrossRef
Association between non-HDL-cholesterol to HDL-cholesterol ratio (NHHR) and COPD: a cross-sectional study of 11,082 Chinese adults with predictive nomogram development
Xiaoli Li, Yunan Wang, Xuanna Zhao
BMC Pulmonary Medicine.2026;[Epub] CrossRef
Dyslipidemias in Chronic Kidney Disease: Pathophysiology and Emerging Therapies
Irene Martin Capon, Edgar V Lerma, Urmila Anandh, Paolo Nikolai H So, Mohamed Hassanein
Indian Journal of Nephrology.2026; 0: 1. CrossRef
Association Between the Triglycerides‐to‐High‐Density Lipoprotein‐Cholesterol (TG/HDL‐C) Ratio and Chronic Kidney Disease: A Systematic Review and Meta‐Analysis of Observational Studies
Mansour Bahardoust, Sheida Shokohyar, Ali Delpisheh, Meisam Haghmoradi, Azin Ghaffari
Endocrinology, Diabetes & Metabolism.2026;[Epub] CrossRef
Association of Klotho gene polymorphism (rs1207568) and serum miR-192 expression with secondary hyperparathyroidism in Egyptian hemodialysis patients
Doaa Mamdouh Aly, Asmaa Mohamed Fteah, Samia El-Shishtawy, Nevine Sherif
Egyptian Journal of Medical Human Genetics.2026;[Epub] CrossRef
Impact of remnant cholesterol on short-term and long-term prognosis in patients with prediabetes or diabetes undergoing coronary artery bypass grafting: a large-scale cohort study
Zhongchen Li, Chunyu Yu, Heng Zhang, Runze Chen, Yan Zhao, Zhe Zheng
Cardiovascular Diabetology.2025;[Epub] CrossRef
Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial
Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra, Eric Gumpricht
Journal of Nutrition and Metabolism.2025;[Epub] CrossRef
The Impact of Glomerular Disease on Dyslipidemia in Pediatric Patients Treated with Dialysis
Edward Zitnik, Elani Streja, Marciana Laster
Nutrients.2025; 17(3): 459. CrossRef
Diabetes, Chronic Kidney Disease, and Vascular Ulcers: Prevention Strategies and Clinical Implications
Stefano Mancin, Alfonso Zarrella, Fabio Petrelli, Simone Cosmai, Daniela Cattani, Diego Lopane, Sarah Scollo, Sara Morales Palomares, Marco Sguanci, Antonella Amendola, Giovanni Cangelosi, Beatrice Mazzoleni
Diabetology.2025; 6(2): 10. CrossRef
Cardiovascular disease burden and associated risk factors in chronic kidney disease
Roshan Bhandari, Srijan Pantha, Ghanashyam Pandey, Richa Paudyal
Indian Journal of Medical Sciences.2025; 77: 120. CrossRef
Association of the Triglyceride-Glucose Index with Body Composition and Laboratory Parameters in Chronic Kidney Disease Stages 3–5
Shan-Shan Xu, Yan-Meng Guan, Hong-Yun Xuan, Xiu-Fang Fan, Ping Lu, Li-Hai Hao
Risk Management and Healthcare Policy.2025; Volume 18: 903. CrossRef
The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and pulmonary function: evidence from NHANES 2007–2012
Miaoyan Liu, Chaofeng Gao, Jinggeng Li, Yibo Zhang, Rui Gao, Chaoting Yang, Jian Zhang
Frontiers in Nutrition.2025;[Epub] CrossRef
Dietary butyric acid intake, kidney function, and survival: The National Health and Nutrition Examination Surveys, 2005–2018
Wei Tang, Zhengyi Long, Yang Xiao, Jingyun Du, Chenyuan Tang, JunXiang Chen, Can Hou
Clinical Nutrition ESPEN.2025; 67: 453. CrossRef
From fat to filter: the effect of adipose tissue-derived signals on kidney function
Nermin Ahmed, Carolina Dalmasso, Meghan B. Turner, Gertrude Arthur, Cole Cincinelli, Analia S. Loria
Nature Reviews Nephrology.2025; 21(6): 417. CrossRef
CHANGES IN CENTRAL AORTIC PRESSURE AND ARTERIAL STIFFNESS IN YOUNG MEN WITH ARTERIAL HYPERTENSION AND CHRONIC KIDNEY DISEASE
O. M. Bilovol, I. I. Kniazkova, V. O. Golovachova, N. V. Kuzminova, D. О. Kіrienko, O. M. Kіrienko, L. P. Abramova
World of Medicine and Biology.2025; 21(91): 26. CrossRef
Analysis of the association between long-term exposure to low-dose ionizing radiation and dyslipidemia and its components in medical radiologists: The mediating role of inflammatory markers
Changyong Wen, Xiaolian Liu, Yiqing Lian, Weizhen Guo, Lingyu Zhang, Yanting Chen, Xin Lan, Mingfang Li, Sufen Zhang, Weixu Huang, Jianming Zou, Huifeng Chen
International Journal of Cardiology Cardiovascular Risk and Prevention.2025; 25: 200406. CrossRef
The protective effect of dietary sphingomyelin supplementation against impaired lipid metabolism in obese mice: a systematic review and meta-analysis of randomized controlled trials
Xiao-Yan Qin, Jie Pan, Yi-Na Liu, Hui-Min Luo, Fang Yang
Food, Nutrition and Health.2025;[Epub] CrossRef
Non-Traditional Cardiovascular Risk Factors: Tailored Assessment and Clinical Implications
Francesco Perone, Marco Bernardi, Luigi Spadafora, Matteo Betti, Stefano Cacciatore, Francesco Saia, Federica Fogacci, Vikash Jaiswal, Elad Asher, Francesco Paneni, Salvatore De Rosa, Maciej Banach, Giuseppe Biondi Zoccai, Pierre Sabouret
Journal of Cardiovascular Development and Disease.2025; 12(5): 171. CrossRef
Associations of cardiac biomarkers with chronic kidney disease and mortality in US individuals without prevalent cardiovascular disease
Haitao Xie, Shi Wang, Li Qian, Peng Yu, Xiaohu Chen, Shuhua Tang, Le Shen
Scientific Reports.2025;[Epub] CrossRef
Accurate Determination of Circulatory Lipids Using a Combination of HILIC-MRM and RPLC-PRM
Kyeong-Seog Kim, Jae-Seung Lee, Seung Seok Han, Joo-Youn Cho
Analytical Chemistry.2025; 97(18): 9713. CrossRef
Glycemic Control in Patients with Diabetes on Peritoneal Dialysis: From Glucose Sparing Approach to Glucose Monitoring
Aleksandra Kezić, Selena Gajić, Ana Račić Ostojić, Ivana Bekić, Ana Bontić, Jelena Pavlović, Marko Baralić, Ljiljana Popović
Life.2025; 15(5): 798. CrossRef
Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim
Journal of Lipid and Atherosclerosis.2025; 14(2): 190. CrossRef
Understanding Atherosclerotic Plaque Cellular Composition: Recent Advances Driven by Single Cell Omics
Esra Cetin, Anne-Catherine Raby
Cells.2025; 14(11): 770. CrossRef
Dynamic changes in metabolic syndrome components and chronic kidney disease risk: a population-based prospective cohort study
Yue Huang, Rong Fu, Juwei Zhang, Jinsong Zhou, Siting Chen, Zheng Lin, Xiaoxu Xie, Zhijian Hu
BMC Endocrine Disorders.2025;[Epub] CrossRef
Causal role of the plasma lipidome in the occurrence and progression of chronic kidney disease: a two-sample Mendelian randomization study
Jiaming Su, Jiyuan Hu, Hongfang Liu, Yan Guo, Yang Shi, Yicheng Zheng, Zhaoxi Dong, Jiayou Liu, Zheyu Xu, Xinhui Yu, Jie Mei, Jing Peng, Lin Wang, Qingqing Liu
Diabetology & Metabolic Syndrome.2025;[Epub] CrossRef
Suppressing ferroptosis via modulating FTH1 by silybin for treatment of renal fibrosis
Jia-Qin Hu, Cang-Qiong Ning, Fang-Cao Pi, Xue-Ni Cai, Jian Zhou, Nan Wang, Li-Li Yu, Hua Zhou, Ying Xie
Phytomedicine.2025; 145: 156937. CrossRef
Synergistic Effect of Banaba Leaf Extract and Policosanol (Raydel®) Ameliorate High Cholesterol and High Galactose-Diet Induced Adverse Events in Zebrafish
Kyung-Hyun Cho, Sang Hyuk Lee, Yunki Lee, Ashutosh Bahuguna, Ji-Eun Kim, Krismala Djayanti, Cheolmin Jeon
Pharmaceuticals.2025; 18(6): 860. CrossRef
Association of Visceral Adiposity with Nephropathy in Patients with Diabetes Mellitus: Data from Chinese and US Cohorts
Fan Zhang, Wenjian Li
Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 1925. CrossRef
Cardiovascular Risk and Its Presentation in Chronic Kidney Disease
Stefan J. Schunk, Paul Zimmermann
Journal of Clinical Medicine.2025; 14(13): 4567. CrossRef
Prevalence and Correlates of Clinical Nephropathy in Patients With Type 2 Diabetes at Abia State Specialist Hospital and Diagnostic Center, Umuahia, Nigeria: A Cross-Sectional Study
Izuchukwu E Okeji, Onyedikachi F Uzor, Christopher C Okafor, Silas U Okafor, Augustine I Airaodion, Obinna J Orji, Isaiah O Abali, Ikpembhosa J Esangbedo, Oladoyin Ogunbayo Jolaoye, Temitayo O Olaotan, Innocent Chima Zacs, Akudo B Umeh, Ugonna Emmanuel
Cureus.2025;[Epub] CrossRef
Mitigating Lipotoxicity: A Potential Mechanism to Delay Chronic Kidney Disease Progression Using Current Pharmacological Therapies
Suthiya Anumas, Reiko Inagi
Nephrology.2025;[Epub] CrossRef
Lipid Accumulation and Insulin Resistance: Bridging Metabolic Dysfunction-Associated Fatty Liver Disease and Chronic Kidney Disease
Xinyi Cao, Na Wang, Min Yang, Chun Zhang
International Journal of Molecular Sciences.2025; 26(14): 6962. CrossRef
Polyunsaturated fatty acids in kidney diseases: Navigating the fine line between healing and damage
Mehrdad Aghasizadeh, Ahmad Reza Bahrami, Maryam M. Matin
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids.2025; 1870(7): 159668. CrossRef
Apitherapy with Royal Jelly and Green Propolis EPP-AF® Improves Cardiovascular Risk Markers in Patients Undergoing Hemodialysis
Julie Ann Kemp, Marianna Mendonça, Paloma Chrispim, Marcia Ribeiro, Isadora Britto, Karen S. Coutinho-Wolino, Marcelo Ribeiro-Alves, Lia S. Nakao, Fernanda Kussi, Eduardo B. Coelho, Andresa A. Berretta, Denise Mafra, Ludmila Cardozo
Toxins.2025; 17(8): 369. CrossRef
Co-Supplementation of Policosanol and Banaba Leaf Extract Exhibited a Cooperative Effect Against Hyperglycemia and Dyslipidemia in Zebrafish: Highlighting Vital Organ Protection Against High-Cholesterol and High-Galactose Diet
Kyung-Hyun Cho, Sang Hyuk Lee, Yunki Lee, Ashutosh Bahuguna, Ji-Eun Kim, Cheolmin Jeon
International Journal of Molecular Sciences.2025; 26(16): 7669. CrossRef
Statins and kidney health: exploring cardiovascular benefits, renal protection, and risks in chronic kidney disease
Rahul Chikatimalla, Yash Vardhan Trivedi, Namita Ruhela, Shubhangi Singh, Amar Lal, Akhil Pawa, Baltej Singh, Rohit Jain
Postgraduate Medicine.2025; 137(7): 588. CrossRef
Intersecting Pathways of Inflammation, Oxidative Stress, and Atherogenesis in the Evaluation of CKD: Emerging Biomarkers PCSK9, EPHX2, AOPPs, and TBARSs
Mohamed-Zakaria Assani, Marius Bogdan Novac, Anda Lorena Dijmărescu, Alexandra-Ștefania Stroe-Ionescu, Mihail Virgil Boldeanu, Isabela Siloși, Lidia Boldeanu
Life.2025; 15(8): 1287. CrossRef
Effect of NPB Capsules Consisting of Allium sativum, Hibiscus sabdariffa, Alisma plantago-aquatica, and Gynostemma pentaphyllum on Lipid Metabolism Disorders
Hoang L. Hiep, Nguyen H. Ngan, Le H. Phu
Tropical Journal of Natural Product Research.2025;[Epub] CrossRef
Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study
Eun Roh, Ji Hye Heo, Han Na Jung, Kyung-Do Han, Jun Goo Kang, Seong Jin Lee, Sung-Hee Ihm
Diabetes & Metabolism Journal.2025; 49(5): 1106. CrossRef
Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential
Shuangshuang Wei, Ying Fu, Yuqing Zeng, Wenwen Wu, Juan Cai, Zheng Dong
Pharmacology & Therapeutics.2025; 275: 108930. CrossRef
Response to the Letter by Mehta and Sah Regarding Article, Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
Mee Kyoung Kim
Journal of Lipid and Atherosclerosis.2025; 14(3): 387. CrossRef
Patterns of lipid profile and genetic variations in South Asians
Mahdi Rahmanian
Cardiovascular Diabetology – Endocrinology Reports.2025;[Epub] CrossRef
Isolated dyslipidemia triggers early kidney injury through fibrotic remodeling, subcellular lipid accumulation, and AMPK overexpression
Mohamed El Fadel Ousmaal, Abderahim Gaceb, Anissa Benali, Jean Giaimis
Ultrastructural Pathology.2025; 49(6): 537. CrossRef
Prevalence, predictors, and outcomes of coronary artery disease diagnosed by angiography in live-related kidney transplant candidates
Muhammad Abdul Mabood Khalil, Nihal Mohammed Sadagah, Hinda Hassan Khideer Mahmood, Ibtisam Ali Alghamdi, Ghada Abdulrahman Buridi, Ahmed Abdelahad Basha, Alfatih Abdalla Altom, Aileen Jean Dela Cruz, Hitham Abdallah Ahmed Abdallah Ragab, Islam Nabil Elsa
BMC Research Notes.2025;[Epub] CrossRef
Stress Pathways in Chronic Kidney Disease: Linking Cortisol, Oxidative Stress, and Inflammation
Maria Motrenikova, Krasimir Boyanov, Neli Bojinova, Anelia Bivolarska
Antioxidants.2025; 14(10): 1259. CrossRef
Progression in adult patients with early-stage chronic kidney disease attending tertiary hospitals in Dodoma, Tanzania: prospective longitudinal study
Denis D Katatwire, Alfred Meremo
BMJ Open.2025; 15(11): e094121. CrossRef
Lipid lowering therapies in chronic kidney disease: A call to action
Jaime Mazón-Ruiz, David Arroyo, Marina de Cos, María Riestra, Emilio Sánchez-Alvarez, Paula González Bores, Jose Luis Hernández, Pablo Corral
Atherosclerosis.2025; 411: 120563. CrossRef
Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations
Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
The Korean Journal of Internal Medicine.2025; 40(6): 876. CrossRef
Direct medical cost analysis in the treatment of chronic kidney disease at Thong Nhat Dong Nai General Hospital in 2024
Tran Ngoc Truong Giang, Tran Nguyen Mai Khanh, Pham Ngoc Bao Vy, Tran Tien An, Tieu Tu Man, Vo Ngoc Yen Nhi
Tạp Chí Khoa học Trường Đại học Quốc tế Hồng Bàng.2025; : 11. CrossRef
Trends in Acute Myocardial Infarction Mortality Among Patients With Chronic Kidney Disease in the United States (1999–2024): A CDC WONDER Database Analysis
Muhammad Shaheer Bin Faheem, Syed Tawassul Hassan, Syeda Umbreen Munir, Sivaram Neppala, Yasar Sattar, Himaja Dutt Chigurupati, Jamal S. Rana, M. Chadi Alraies
Cardiology in Review.2025;[Epub] CrossRef
Chronic kidney disease and cardiovascular risk: Pathophysiology and interventional approaches – systematic review
Muhammad Bari Hassan, Sadia Siddique, Sandeep Kumar Maheshwari, Fnu Neelam, Fnu Neha, Bhawna Lohana, Kiran Lohana, Bismillah Athar Dar, Hina Kumari, Raja Pawan, Payal Bai, Sitara Jabeen, Ali Umair, Ali Karim, Zaghum Abbas, Ugal Kishore, Vikram Kumar, Abid
Medicine.2025; 104(49): e46189. CrossRef
Obesity-related glomerulopathy, A growing kidney burden in the obesity pandemic
Mahtab Mashayekhi, Jonathan E. Zuckerman, Sahar H. Koubar, Junnan Wu, Jianbo Qing, Amir Abdipour, Edgar Lerma, Warren Peters, Sayna Norouzi
Clinical and Experimental Nephrology.2025;[Epub] CrossRef
Association between hemoglobin-to-creatinine ratio and all-cause mortality in patients with coronary artery disease
Bo Kang, Chun Zhang, Jie Li, Liang Chen
The Egyptian Heart Journal.2025;[Epub] CrossRef
Cuban Sugarcane Wax Alcohol Supplementation Prevents Brain and Eye Damages of Zebrafish Exposed to High-Cholesterol and High-Galactose Diet for 30 Weeks: Protection of Myelin, Cornea, and Retina
Kyung-Hyun Cho, Ashutosh Bahuguna, Cheolmin Jeon, Sang Hyuk Lee, Yunki Lee, Seung Hee Baek, Chae-Eun Yang, Ji-Eun Kim, Krismala Djayanti
Antioxidants.2025; 14(12): 1453. CrossRef
Epicardial adipose tissue: an overtly concealed contributor to cardiovascular events in chronic kidney disease patients
Liqin Cui, Min Yang
Lipids in Health and Disease.2025;[Epub] CrossRef
Statin Therapy and Lipid Indices in Chronic Kidney Disease: A Systematic Review and Meta-analysis of Randomized Control Trials
Jafar Karami, Bahman Razi, Danyal Imani, Saeed Aslani, Mahdi Pakjoo, Mahdieh Fasihi, Keyhan Mohammadi, Amirhossein Sahebkar
Current Pharmaceutical Design.2024; 30(5): 362. CrossRef
Lipoprotein glomerulopathy with markedly increased arterial stiffness successfully treated with a combination of fenofibrate and losartan: a case report
Junichiro Kato, Hideo Okonogi, Go Kanzaki, Haruki Katsumata, Yasuyuki Nakada, Makoto Sagasaki, Kazumasa Komine, Kenji Ito, Takao Saito, Akira Matsunaga, Koh Tokutou, Kazuho Honda, Nobuo Tsuboi, Takashi Yokoo
BMC Nephrology.2024;[Epub] CrossRef
Atherogenic index of plasma: a new indicator for assessing the short-term mortality of patients with acute decompensated heart failure
Meng Yu, Hongyi Yang, Maobin Kuang, Jiajun Qiu, Changhui Yu, Guobo Xie, Guotai Sheng, Yang Zou
Frontiers in Endocrinology.2024;[Epub] CrossRef
Association between lipid accumulation product index and chronic kidney disease: A systematic review and meta-analysis
Feixiang Wu, Chenmin Cui, Junping Wu, Yunqing Wang
Experimental and Therapeutic Medicine.2024;[Epub] CrossRef
Potential impact of sodium glucose co-transporter (SGLT2) inhibitors on cholesterol fractions in stage 3 chronic kidney disease
Rabab Mahmoud Ahmed, Nehal Kamal Rakha, Ahmed Yousry, Amin Roshdy Soliman
The Egyptian Journal of Internal Medicine.2024;[Epub] CrossRef
Pulmonary Hypertension in Hemodialysis Patients and Its Determinants: A Hospital Based Cross-Sectional Study
Qingfei Yu, Qin Zhang
International Journal of General Medicine.2024; Volume 17: 3919. CrossRef
Relationship Between Serum Uromodulin as a Marker of Kidney Damage and Metabolic Status in Patients with Chronic Kidney Disease of Non-Diabetic Etiology
Radmila Žeravica, Branislava Ilinčić, Dragan Burić, Ana Jakovljević, Veljko Crnobrnja, Dalibor Ilić, Marija Vukmirović Papuga
International Journal of Molecular Sciences.2024; 25(20): 11159. CrossRef
Dyslipidemia in Peritoneal Dialysis: Implications for Peritoneal Membrane Function and Patient Outcomes
Natalia Stepanova
Biomedicines.2024; 12(10): 2377. CrossRef
Causal associations between kidney function and aortic valve stenosis: a bidirectional Mendelian randomization analysis
Wanqian Pan, Le Zhou, Rui Han, Xiaojiao Du, Weixiang Chen, Tingbo Jiang
Renal Failure.2024;[Epub] CrossRef
U-shaped association between dietary niacin intake and chronic kidney disease among US elderly: a nationwide cross-sectional study
Zhouzhou Xie, Shansen Peng, Gejun Ou, Xiaoqi Zhou, Guihao Zhang, Huiming Jiang, Tianhui Zhang, Nanhui Chen
Frontiers in Endocrinology.2024;[Epub] CrossRef
Association between dried fruit intake and kidney function: research from univariate and multivariate Mendelian randomized studies
Yuhang Gao, Xinghai Yue, Wanchao Zhao, Fang Yuan
Frontiers in Nutrition.2024;[Epub] CrossRef
The Dual Burden: Exploring Cardiovascular Complications in Chronic Kidney Disease
Alfredo Caturano, Raffaele Galiero, Maria Rocco, Giuseppina Tagliaferri, Alessia Piacevole, Davide Nilo, Giovanni Di Lorenzo, Celestino Sardu, Vincenzo Russo, Erica Vetrano, Marcellino Monda, Raffaele Marfella, Luca Rinaldi, Ferdinando Carlo Sasso
Biomolecules.2024; 14(11): 1393. CrossRef
Association between the EHBP1 SNPs and dyslipidemia in the end-stage renal disease patients with dialysis in Chinese Han population
Yan-Fei Lai, Zhong-E Liang, Chun-Xiang Wu, Min Zhang, Zong-Hu Shi, Xiao-Yan Meng, Chun-Xiao Liu
Lipids in Health and Disease.2024;[Epub] CrossRef

Original Article

Cardiovascular Risk/Epidemiology
Cardiovascular Outcomes according to Comorbidities and Low-Density Lipoprotein Cholesterol in Korean People with Type 2 Diabetes Mellitus: Min Kyong Moon, Junghyun Noh, Eun-Jung Rhee, Sang Hyun Park, Hyeon Chang Kim, Byung Jin Kim, Hae Jin Kim, Seonghoon Choi, Jin Oh Na, Young Youl Hyun, Bum Joon Kim, Kyung-Do Han, In-Kyung Jeong, on Behalf of the Committee of Practice Guideline of Korean Lipid and Atheroscelerosis; Diabetes Metab J. 2023;47(1):45-58. Published online January 26, 2023; DOI: https://doi.org/10.4093/dmj.2021.0344

10,263 View
370 Download
8 Web of Science
13 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
There are no clear data to support the cardiovascular (CV) risk categories and low-density lipoprotein cholesterol (LDL-C) treatment goals in Korean people with type 2 diabetes mellitus (T2DM). We evaluated the incidence of cardiovascular disease (CVD) according to comorbidities and suggested LDL-C treatment goals in Korean people with T2DM in nationwide cohort data.
Methods
Using the Korean National Health Insurance Service database, 248,002 people aged 30 to 90 years with T2DM who underwent routine health check-ups during 2009 were included. Subjects with previous CVD were excluded from the study. The primary outcome was incident CVD, defined as a composite of myocardial infarction and ischemic stroke during the follow-up period from 2009 to 2018.
Results
The mean age of the study participants was 59.6±10.9 years, and median follow-up period was 9.3 years. CVD incidence increased in the order of DM duration of 5 years or more (12.04/1,000 person-years), hypertension (HT) (12.27/1,000 personyears), three or more CV risk factors (14.10/1,000 person-years), and chronic kidney disease (18.28/1,000 person-years). The risk of incident CVD increased linearly from an LDL-C level of ≥70 mg/dL in most patients with T2DM. In T2DM patients without HT or with a DM duration of less than 5 years, the CVD incidence increased from LDL-C level of ≥100 mg/dL.
Conclusion
For primary prevention of CVD in Korean adults with T2DM, it can be helpful to lower LDL-C targets when there are chronic kidney disease, HT, a long duration of diabetes mellitus, or three or more CV risk factors.

Citations

Citations to this article as recorded by

Clinical value of serum miR-214-3p expression in the diagnosis of type 2 diabetes mellitus and prediction of its chronic complications
Meng Ding, Siyu Yang, Junli Li, Lie Ma, Cunyou Xiong, Jie Zhang
BMC Endocrine Disorders.2025;[Epub] CrossRef
Cholesterol and Cardiovascular Risk in Type 2 Diabetes: The Role of Kidney Function
Ji-Hyun Kim, Seung-Hwan Lee, Kyu Na Lee, Kyungdo Han, Mee Kyoung Kim
Journal of Lipid and Atherosclerosis.2025; 14(2): 190. CrossRef
2025 Clinical Practice Guidelines for Diabetes Management in Korea: Recommendation of the Korean Diabetes Association
Shinae Kang, Seon Mee Kang, Jong Han Choi, Seung-Hyun Ko, Bo Kyung Koo, Hyuk-Sang Kwon, Mi Kyung Kim, Sang Yong Kim, Soo-Kyung Kim, Young-eun Kim, Eun Sook Kim, Jae Hyeon Kim, Chong Hwa Kim, Ji Min Kim, Hae Jin Kim, Min Kyong Moon, Sun Joon Moon, Jun Sung
Diabetes & Metabolism Journal.2025; 49(4): 582. CrossRef
Heterogeneity in the development of diabetes-related complications: narrative review of the roles of ancestry and geographical determinants
Andrea O. Y. Luk, Yingnan Fan, Baoqi Fan, Edith W. K. Chow, Tony C. K. O
Diabetologia.2025; 68(11): 2386. CrossRef
Adherence-based experiences with a personalized self-care program for type 2 diabetes in South Korea: a mixed-methods study
Haejung Lee, DaeEun Lee, Mihwan Kim
Journal of Korean Biological Nursing Science.2025; 27(4): 706. CrossRef
2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association
Jun Sung Moon, Shinae Kang, Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, Yoon Ju Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang
Diabetes & Metabolism Journal.2024; 48(4): 546. CrossRef
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Diabetes & Metabolism Journal.2023; 47(1): 1. CrossRef
Optimal Low-Density Lipoprotein Cholesterol Level for Primary Prevention in Koreans with Type 2 Diabetes Mellitus
Ji Yoon Kim, Nam Hoon Kim
Diabetes & Metabolism Journal.2023; 47(1): 42. CrossRef
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Journal of Lipid and Atherosclerosis.2023; 12(1): 12. CrossRef
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
Ye Seul Yang
The Journal of Korean Diabetes.2023; 24(3): 135. CrossRef
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Nan Hee Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, YoonJu Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae J
Diabetes & Metabolism Journal.2023; 47(5): 575. CrossRef
Management of Dyslipidemia in Patients with Diabetes Mellitus
Kyung Ae Lee
The Journal of Korean Diabetes.2023; 24(3): 111. CrossRef
Significant Gap Between Guidelines and Practice in the Management of LDL Cholesterol: Insight From the Survey of the Korean Society of Myocardial Infarction
Sang Yeub Lee, Kyung Hoon Cho, Jang Hoon Lee, Young Joon Hong, Jin yong Hwang, Myung Ho Jeong, Weon Kim
Journal of Korean Medical Science.2023;[Epub] CrossRef

Reviews

Guideline/Fact Sheet
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement: Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon, on Behalf of Committee of Clinical Practice Guideline, Korean Diabetes Association and Clinical Practice Guideline Committee, Korean Society of Lipid and Atherosclerosis; Diabetes Metab J. 2023;47(1):1-9. Published online January 20, 2023; DOI: https://doi.org/10.4093/dmj.2022.0448

10,198 View
476 Download
28 Web of Science
19 Crossref

Abstract PDF PubReader ePub

Dyslipidemia in patients with diabetes is an important treatment target as a modifiable risk factor for cardiovascular disease (CVD). Although the primary treatment goal for dyslipidemia is to control low-density lipoprotein cholesterol (LDL-C), achieving this goal remains suboptimal according to recent studies. It is important to set the target goal for LDL-C control based on an accurate risk assessment for CVD. Here, we summarize the latest evidence on lipid management in patients with diabetes and present a consensus of the Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis on the treatment goals of LDL-C according to the duration of diabetes, presence of CVD, target organ damage, or major cardiovascular risk factors. In patients with type 2 diabetes mellitus (T2DM) and CVD, an LDL-C goal of <55 mg/dL and a reduction in LDL-C level by 50% or more from the baseline is recommended. For the primary prevention of CVD in patients with T2DM with a duration of diabetes ≥10 years, major cardiovascular risk factors, or target organ damage, an LDL-C goal of <70 mg/dL is recommended. In patients with T2DM with a duration of diabetes <10 years and no major cardiovascular risk factors, an LDL-C goal of <100 mg/dL is recommended.

Citations

Citations to this article as recorded by

Efficacy and safety of switching to ezetimibe 10 mg/rosuvastatin 2.5 mg in Korean patients with type 2 diabetes mellitus and dyslipidaemia: A multicentre, prospective study (EROICA study)
Sangmo Hong, Won J. Kim, Sungrae Kim, Jung H. Park, Eun S. Kang, Min K. Moon, Jae T. Kim, Ji‐Oh Mok, Ki Y. Lee, Cheol‐Young Park, Chang B. Lee
Diabetes, Obesity and Metabolism.2026; 28(2): 906. CrossRef
Impact of Remnant Cholesterol on the Risk for End-Stage Renal Disease in Type 2 Diabetes Mellitus: A Nationwide Population-Based Cohort Study (Diabetes Metab J 2025;49:1106-15)
Eun Roh, Ji Hye Heo, Kyung-Do Han, Jun Goo Kang
Diabetes & Metabolism Journal.2026; 50(1): 203. CrossRef
Are lipid-lowering therapies used according to the guidelines?: A real-world retrospective study of 1001 patients with type 2 diabetes
Muhammet Fatih Şahin, Ali Erol, Gökhan Bayrak, Ali Şahin
Medicine.2026; 105(4): e47360. CrossRef
Atherosclerotic Cardiovascular Disease Risk Prediction Models in China, Japan, and Korea
Patricia K. Nguyen, Dong Zhao, Tomonori Okamura, Hyeon Chang Kim, Nathan D. Wong, Eugene Yang
JACC: Asia.2025; 5(3): 333. CrossRef
The Impact of Ketogenic Capacity on Lipid Profile in Individuals with Prediabetes or Newly Diagnosed Type 2 Diabetes
Jaehyun Bae, Minyoung Lee, Yong-ho Lee, Sang-Guk Lee, Byung-Wan Lee
International Journal of Molecular Sciences.2025; 26(17): 8566. CrossRef
2025 Clinical Practice Guidelines for Diabetes: Cardiovascular Risk Management
Hae Jin Kim
The Journal of Korean Diabetes.2025; 26(3): 164. CrossRef
Managing dyslipidemia in chronic kidney disease: a comprehensive overview of evidence and recommendations
Ji Yoon Kim, Suk Min Chung, Nam Hoon Kim
The Korean Journal of Internal Medicine.2025; 40(6): 876. CrossRef
Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118. CrossRef
Clinical Characteristics of Patients With Statin Discontinuation in Korea: A Nationwide Population-Based Study
Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
Journal of Lipid and Atherosclerosis.2024; 13(1): 41. CrossRef
Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
Diabetes & Metabolism Journal.2024; 48(2): 184. CrossRef
Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
Cardiovascular Diabetology.2024;[Epub] CrossRef
The mediating effect of TyG and its derived indices in the association between OSAHS and atherosclerosis in patients with T2DM
Ling Ding, Xiaohong Jiang
Sleep and Breathing.2024; 28(6): 2469. CrossRef
Fenofibrate to prevent amputation and reduce vascular complications in patients with diabetes: FENO-PREVENT
Eu Jeong Ku, Bongseong Kim, Kyungdo Han, Seung-Hwan Lee, Hyuk-Sang Kwon
Cardiovascular Diabetology.2024;[Epub] CrossRef
Dyslipidemia Fact Sheet in South Korea, 2022
Eun-Sun Jin, Jee-Seon Shim, Sung Eun Kim, Jae Hyun Bae, Shinae Kang, Jong Chul Won, Min-Jeong Shin, Heung Yong Jin, Jenny Moon, Hokyou Lee, Hyeon Chang Kim, In-Kyung Jeong
Diabetes & Metabolism Journal.2023; 47(5): 632. CrossRef
2023 Clinical Practice Guidelines for Diabetes
Min Kyong Moon
The Journal of Korean Diabetes.2023; 24(3): 120. CrossRef
2023 Clinical Practice Guidelines for Diabetes Mellitus of the Korean Diabetes Association
Jong Han Choi, Kyung Ae Lee, Joon Ho Moon, Suk Chon, Dae Jung Kim, Hyun Jin Kim, Nan Hee Kim, Ji A Seo, Mee Kyoung Kim, Jeong Hyun Lim, YoonJu Song, Ye Seul Yang, Jae Hyeon Kim, You-Bin Lee, Junghyun Noh, Kyu Yeon Hur, Jong Suk Park, Sang Youl Rhee, Hae J
Diabetes & Metabolism Journal.2023; 47(5): 575. CrossRef
Management of Dyslipidemia in Patients with Diabetes Mellitus
Kyung Ae Lee
The Journal of Korean Diabetes.2023; 24(3): 111. CrossRef
2023 Clinical Practice Guidelines for Diabetes: Management of Cardiovascular Risk Factors
Ye Seul Yang
The Journal of Korean Diabetes.2023; 24(3): 135. CrossRef
Dyslipidemia Fact Sheet in South Korea, 2022
Eun-Sun Jin, Jee-Seon Shim, Sung Eun Kim, Jae Hyun Bae, Shinae Kang, Jong Chul Won, Min-Jeong Shin, Heung Yong Jin, Jenny Moon, Hokyou Lee, Hyeon Chang Kim, In-Kyung Jeong
Journal of Lipid and Atherosclerosis.2023; 12(3): 237. CrossRef

Drug/Regimen
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins: Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi; Diabetes Metab J. 2022;46(4):517-532. Published online July 27, 2022; DOI: https://doi.org/10.4093/dmj.2022.0198; Correction in: Diabetes Metab J 2022;46(5):817

26,799 View
1,229 Download
57 Web of Science
61 Crossref

Abstract PDF PubReader ePub

Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been an unmet clinical need for novel lipid-lowering agents that can target low-density lipoprotein cholesterol (LDL-C) and other atherogenic particles. During the past decade, several drugs have been developed for the treatment of dyslipidemia. Inclisiran, a small interfering RNA that targets proprotein convertase subtilisin/kexin type 9 (PCSK9), shows comparable effects to that of PCSK9 monoclonal antibodies. Bempedoic acid, an ATP citrate lyase inhibitor, is a valuable treatment option for the patients with statin intolerance. Pemafibrate, the first selective peroxisome proliferator-activated receptor alpha modulator, showed a favorable benefit-risk balance in phase 2 trial, but the large clinical phase 3 trial (PROMINENT) was recently stopped for futility based on a late interim analysis. High dose icosapent ethyl, a modified eicosapentaenoic acid preparation, shows cardiovascular benefits. Evinacumab, an angiopoietin-like 3 (ANGPTL3) monoclonal antibody, reduces plasma LDL-C levels in patients with refractory hypercholesterolemia. Novel antisense oligonucleotides targeting apolipoprotein C3 (apoC3), ANGPTL3, and lipoprotein(a) have significantly attenuated the levels of their target molecules with beneficial effects on associated dyslipidemias. Apolipoprotein A1 (apoA1) is considered as a potential treatment to exploit the athero-protective effects of high-density lipoprotein cholesterol (HDL-C), but solid clinical evidence is necessary. In this review, we discuss the mode of action and clinical outcomes of these novel lipid-lowering agents beyond statins.

Citations

Citations to this article as recorded by

CURRENT ADVANCES IN LIPOPROTEIN(A) MANAGEMENT: CLINICAL SIGNIFICANCE AND EMERGING THERAPIES
Szymon Zysiak, Rafał Bednarczyk, Natalia Bednarczyk, Agnieszka Kurek, Natalia Krajewska, Aleksandra Lejman, Aleksandra Mazurkiewicz, Hubert Sidor, Monika Wołosik, Radosław Krzysztof Binkowski
International Journal of Innovative Technologies in Social Science.2026;[Epub] CrossRef
The mechanism of perilla oil in regulating lipid metabolism
Jiawei Xia, Yi Wang, Xin Li, Li Liu, Pin Zhang, Wendong Dai, Peng Luo, Guoze Wang, Yanhong Li
Food Chemistry.2025; 476: 143318. CrossRef
The effect of vitamin E supplementation on serum low-density lipoprotein oxidization: A systematic review and meta-analysis of clinical trials
Sepide Amini, Fatemeh Navab, Mohammad Hossein Rouhani, Tannaz Jamialahmadi, Mohammad Bagherniya, Prashant Kesharwani, Amirhossein Sahebkar
European Journal of Pharmacology.2025; 997: 177491. CrossRef
Acromegaly and the risk of cancer: a nationwide population-based cohort study in Korea
Yeo Song Kim, Jae-Seung Yun, Hyunho Kim, Sin Soo Jeun, Bongseong Kim, Sea-Won Lee, Jung Eun Lee, Kyuho Kim, Seung-Hyun Ko, Yu-Bae Ahn, Kyungdo Han, Seung Ho Yang
European Journal of Endocrinology.2025; 192(3): 220. CrossRef
Cholesterol-modifying strategies for Alzheimer disease: promise or fallacy?
Katia Azarfar, Boris Decourt, Brandon Sanchez Camacho, John Joshua Lawrence, Tania R. Omondi, Marwan N. Sabbagh
Expert Review of Neurotherapeutics.2025; 25(5): 521. CrossRef
Recent Advances in the Management of Dyslipidemia: A Systematic Review
Huang Jacky Xiao Feng, Yousaf Adil, Moon Julie, Ahmed Ramiz, Uppal Krishma, Sudhakar Pemminati
Cureus.2025;[Epub] CrossRef
Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins
Gala Araujo, Leidy Marian Valencia, Agata Martin-Ozimek, Yosdel Soto, Spencer D. Proctor
Frontiers in Immunology.2025;[Epub] CrossRef
Statins and adhesion molecules: a review of a novel pleiotropic property of statins
Mahvash Sadeghi, Sajad Dehnavi, Sanaz Keshavarz Shahbaz, Khadijeh Koushki, Alexandra E. Butler, Tannaz Jamialahmadi, Amirhossein Sahebkar
Immunologic Research.2025;[Epub] CrossRef
Discordance of Small Dense LDL Cholesterol Beyond LDL Cholesterol or Non–HDL Cholesterol and Carotid Plaque
Jinqi Wang, Xiaoyu Zhao, Yanchen Zhao, Rui Jin, Yunfei Li, Jiahe Wang, Yueruijing Liu, Zhiyuan Wu, Xiuhua Guo, Lixin Tao
JACC: Asia.2025; 5(8): 1012. CrossRef
Hyperlipidemia and atherosclerosis: experimental models
K. I. Davletova, E. L. Chernolovskaya
Bulletin of Siberian Medicine.2025; 24(2): 141. CrossRef
CORRECTION OF DYSLIPIDEMIA: HISTORICAL ASPECT AND CURRENT VIEW OF THE PROBLEM (REVIEW, PART IІ)
Dmytro D. Diachuk, Galina Z. Moroz, Oleksandr M. Tkalenko
Clinical and Preventive Medicine.2025; (4): 134. CrossRef
Targeting the angiopoietin-like protein 3/8 complex with a monoclonal antibody in patients with mixed hyperlipidemia: a phase 1 trial
Daniel Gaudet, Malgorzata Gonciarz, Xi Shen, Jennifer K. Leohr, Thomas P. Beyer, Jonathan W. Day, Garrett R. Mullins, Eugene Y. Zhen, Maryalice Hartley, Miriam Larouche, Robert J. Konrad, Olivier Benichou, Giacomo Ruotolo
Nature Medicine.2025; 31(8): 2632. CrossRef
Post-transcriptional targeting of PCSK9 by microRNAs: From mechanisms to therapeutic potential
Maryam Mahjoubin-Tehran, Samaneh Rezaei, Tannaz Jamialahmadi, Prashant Kesharwani, Amirhossein Sahebkar
Human Gene.2025; 45: 201456. CrossRef
Assessing Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Patients at a Tertiary Hospital, Addis Ababa, Ethiopia
Edomias Adyamseged Berhe, Rediet Ambachew Sema, Yididya Mehari Tesfaye, Abel Andargie Berhane, Mikale Dawit, Ephrem Mamo Gebrehiwot, Subah Abderehim Yesuf, Balamurugan Ramatchandirin
Journal of Diabetes Research.2025;[Epub] CrossRef
Dendrobium huoshanense C. Z. Tang & S. J. Cheng alleviates atherosclerosis by reducing lipid and improving vascular endothelial dysfunction
Xiang-Cheng Fan, Wei-You Cao, Min-Yang He, Hui-Kai Wang, Qing Hao, Wen-Jing Liu, Zhao-Ying Ren, Li-Jun Wang, Jing-Yu Wang, Fei-Xue Wang, Lin Jiang, Qiu-Sheng Zheng, Jun Ma, Feng Zhang, Ji-Chun Han, Lei Zheng
Frontiers in Nutrition.2025;[Epub] CrossRef
Two Sides of Triglycerides in Atherogenesis: An Essential Contributor
Anastasia V Poznyak, Sergey Kozlov, Gulalek A Babayeva, Vasily N Sukhorukov, Alexander N Orekhov
Clinical Medicine Insights: Cardiology.2025;[Epub] CrossRef
Time-Restricted Eating, ANGPTL4, and Reduction in Residual Cardiovascular Risk
Alejandro Gugliucci
Journal of Clinical Medicine.2025; 14(19): 7026. CrossRef
Genetic insights into lipid traits and atherosclerosis risk: a Mendelian randomization and polygenic risk score analysis
Hongliang Zhang, Xiaoyu Long, Guannan Niu, Wence Shi, Zhenyan Zhao, Dejing Feng, Hui Sun, Yongjian Wu
International Journal of Surgery.2025; 111(10): 6802. CrossRef
Statins as Modulators of Epithelial to Mesenchymal Transition in Cardiovascular-Kidney-Metabolic Syndrome: a Comprehensive Review of Mechanisms and Therapeutic Implications
Fatemeh Askarizadeh, Wael Almahmeed, Kasim Sakran Abass, Salim Virani, Amirhossein Sahebkar
Current Atherosclerosis Reports.2025;[Epub] CrossRef
Gut microbiota–cholesterol crosstalk in cardiovascular diseases: mechanisms, metabolites, and therapeutic modulation
Mohammad Abavisani, Seyed Mohammad Sajjadi, Negar Ebadpour, Sercan Karav, Amirhossein Sahebkar
Nutrition & Metabolism.2025;[Epub] CrossRef
Innovations in Diagnosis and Treatment of Coronary Artery Disease
Salaheldin Agamy, Sheref Zaghloul, Zahid Khan, Ahmed Shahin, Ramy Kishk, Ahmed Smman, Luciano Candilio
Diagnostics.2025; 16(1): 98. CrossRef
Clinical Determinants and Prognostic Significance of Circulating Angiopoietin-Like Protein 3 Levels in Patients With Chronic Coronary Syndrome
Hiroki Tanaka, Yunosuke Matsuura, Kinuko Yamamoto, Soichi Komaki, Masashi Yamaguchi, Kohei Moribayashi, Takeshi Ideguchi, Michikazu Nakai, Toshihiro Tsuruda, Koichi Kaikita
Circulation Reports.2025;[Epub] CrossRef
The role of adherence in patients with chronic diseases
Michel Burnier
European Journal of Internal Medicine.2024; 119: 1. CrossRef
Bempedoic acid: new evidence and recommendations on use
Kristina Paponja, Ivan Pećin, Željko Reiner, Maciej Banach
Current Opinion in Lipidology.2024; 35(1): 41. CrossRef
Genetic insights into repurposing statins for hyperthyroidism prevention: a drug-target Mendelian randomization study
Anqi Huang, Xinyi Wu, Jiaqi Lin, Chiju Wei, Wencan Xu
Frontiers in Endocrinology.2024;[Epub] CrossRef
Targeting host-specific metabolic pathways—opportunities and challenges for anti-infective therapy
Monika I. Konaklieva, Balbina J. Plotkin
Frontiers in Molecular Biosciences.2024;[Epub] CrossRef
Neutrophil Extracellular Traps (NETs) and Atherosclerosis: Does Hypolipidemic Treatment Have an Effect?
Petros Adamidis, Despoina Pantazi, Iraklis Moschonas, Evangelos Liberopoulos, Alexandros Tselepis
Journal of Cardiovascular Development and Disease.2024; 11(3): 72. CrossRef
Modulating effects of crocin on lipids and lipoproteins: Mechanisms and potential benefits
Habib Yaribeygi, Mina Maleki, Farin Rashid-Farrokhi, Payman Raise Abdullahi, Mohammad Amin Hemmati, Tannaz Jamialahmadi, Amirhossein Sahebkar
Heliyon.2024; 10(7): e28837. CrossRef
Assessing the Benefits of Lifestyle Influences on Cardiovascu-lar Health After Acute Coronary Syndrome
Marius Rus, Claudia Elena Stanis, Paula Marian, Lilliana Oana Pobirci, Loredana Ioana Banszki, Veronica Huplea, Gheorghe Adrian Osiceanu, Bianca-Maria Pop, Gabriela Dogaru, Felicia Liana Andronie-Cioara
Balneo and PRM Research Journal.2024; 15(Vol.15, no): 660. CrossRef
Comprehensive mendelian randomization analysis of plasma proteomics to identify new therapeutic targets for the treatment of coronary heart disease and myocardial infarction
Ziyi Sun, Zhangjun Yun, Jianguo Lin, Xiaoning Sun, Qingqing Wang, Jinlong Duan, Cheng Li, Xiaoxiao Zhang, Siyu Xu, Zeqi Wang, Xingjiang Xiong, Kuiwu Yao
Journal of Translational Medicine.2024;[Epub] CrossRef
Hypercholesterolemia: a literature review on management using tafolecimab: a novel member of PCSK9 monoclonal antibodies
Zaheer Qureshi, Mikail Khanzada, Adnan Safi, Eeshal Fatima, Faryal Altaf, Timothy J. Vittorio
Annals of Medicine & Surgery.2024; 86(5): 2818. CrossRef
Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
Galenika Medical Journal.2024; 3(9): 31. CrossRef
Lipid Variability Induces Endothelial Dysfunction by Increasing Inflammation and Oxidative Stress
Marie Rhee, Joonyub Lee, Eun Young Lee, Kun-Ho Yoon, Seung-Hwan Lee
Endocrinology and Metabolism.2024; 39(3): 511. CrossRef
Exploring the Perceptions and Behaviours of UK Prescribers Concerning Novel Lipid-Lowering Agent Prescriptions: A Qualitative Study
Sarah Baig, Shahrauz Mughal, Yousuf Murad, Mandeep Virdee, Zahraa Jalal
Pharmacy.2024; 12(4): 104. CrossRef
Need of education and training of healthcare professionals on the PCSK9 inhibitors in cardiovascular disease
Jan Schjøtt, Kristine Heitmann
European Journal of Cardiovascular Nursing.2024; 23(8): e191. CrossRef
CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitis
Xize Wu, Changbin Yuan, Jiaxiang Pan, Yi Zhou, Xue Pan, Jian Kang, Lihong Ren, Lihong Gong, Yue Li
Scientific Reports.2024;[Epub] CrossRef
Lessons from PROMINENT and prospects for pemafibrate
Jean-Charles Fruchart, Jamila Fruchart-Najib, Shizuya Yamashita, Peter Libby, Koutaro Yokote, Tatsuhiko Kodama, Yohei Tomita, Paul M. Ridker, Michel P. Hermans, Alberto Zambon
Cardiovascular Diabetology.2024;[Epub] CrossRef
A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3
Qianqian Xiao, Luyun Wang, Jing Wang, Man Wang, Dao Wen Wang, Hu Ding
Molecular Metabolism.2024; 88: 102011. CrossRef
Advances in pharmacotherapy of dyslipidemia
Harshitha Chinta
National Journal of Pharmacology and Therapeutics.2024; 2(2): 68. CrossRef
ANGPTL3 as a target for treating lipid disorders in type 2 diabetes patients
Jingfei Chen, Qin Luo, Yanfeng Yi, Jiangang Wang, Pengfei Chen, Fei Luo, Zhenfei Fang
Lipids in Health and Disease.2024;[Epub] CrossRef
Assessing the effects of HMGCR, LPL, and PCSK9 inhibition on sleep apnea: Mendelian randomization analysis of drug targets
Wei Tan, Xiujuan Deng, Xiaoning Tan, Guangbo Tan
Medicine.2024; 103(43): e40194. CrossRef
Causal association between remnant cholesterol level and risk of cardiovascular diseases: a bidirectional two sample mendelian randomization study
Lei Zhong, Bo Xie, Hai-Li Wang, Xiao-Wei Ji
Scientific Reports.2024;[Epub] CrossRef
A bibliometric analysis of immunotherapy for atherosclerosis: trends and hotspots prediction
Jing-Hui Wang, Guan-Rui Pan, Long Jiang
Frontiers in Immunology.2024;[Epub] CrossRef
Liver cancer cells as the model for developing liver-targeted RNAi therapeutics
Beibei Hou, Linhui Qin, Linfeng Huang
Biochemical and Biophysical Research Communications.2023; 644: 85. CrossRef
Insights into Causal Cardiovascular Risk Factors from Mendelian Randomization
C. M. Schooling, J. V. Zhao
Current Cardiology Reports.2023; 25(2): 67. CrossRef
Secoisolariciresinol diglucoside and anethole ameliorate lipid abnormalities, oxidative injury, hypercholesterolemia, heart, and liver conditions
Sana Noreen, Habib‐ur Rehman, Tabussam Tufail, Huma Badar Ul Ain, Chinaza Godswill Awuchi
Food Science & Nutrition.2023; 11(6): 2620. CrossRef
Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis
Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán, Agustín Blanco, Mariano Blasco, José Luís Díaz Díaz, Ángel Díaz Rodríguez, Alipio Mangas, Vicente Pascual, Juan Pedro Botet, Pablo Pérez Martínez
Clínica e Investigación en Arteriosclerosis.2023; 35(4): 206. CrossRef
Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum
Michael J. Wilkinson, Norman E. Lepor, Erin D. Michos
Journal of the American Heart Association.2023;[Epub] CrossRef
The cell origins of foam cell and lipid metabolism regulated by mechanical stress in atherosclerosis
Zhi Ouyang, Jian Zhong, Junyi Shen, Ye Zeng
Frontiers in Physiology.2023;[Epub] CrossRef
Triglyceride-Rich Lipoprotein Metabolism: Key Regulators of Their Flux
Alejandro Gugliucci
Journal of Clinical Medicine.2023; 12(13): 4399. CrossRef
Remnant cholesterol, vascular risk, and prevention of atherosclerosis
Xavier Pintó, Marta Fanlo, Virginia Esteve, Jesús Millán
Clínica e Investigación en Arteriosclerosis (English Edition).2023; 35(4): 206. CrossRef
Antibiotics and Lipid-Modifying Agents: Potential Drug–Drug Interactions and Their Clinical Implications
Marios Spanakis, Danny Alon-Ellenbogen, Petros Ioannou, Nikolaos Spernovasilis
Pharmacy.2023; 11(4): 130. CrossRef
Advances in Treatment of Dyslipidemia
Jill Dybiec, Wiktoria Baran, Bartłomiej Dąbek, Piotr Fularski, Ewelina Młynarska, Ewa Radzioch, Jacek Rysz, Beata Franczyk
International Journal of Molecular Sciences.2023; 24(17): 13288. CrossRef
Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
Elena Valeria Fuior, Evangelia Zvintzou, Theodosios Filippatos, Katerina Giannatou, Victoria Mparnia, Maya Simionescu, Anca Violeta Gafencu, Kyriakos E. Kypreos
Biomedicines.2023; 11(10): 2696. CrossRef
Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles
Lixin Du, Huiling Lu, Yifei Xiao, Zhihua Guo, Ya Li
Scientific Reports.2023;[Epub] CrossRef
Dysregulation of Cholesterol Homeostasis in Ovarian Cancer
Zahraa Qusairy, Anne Gangloff, Shuk On Annie Leung
Current Oncology.2023; 30(9): 8386. CrossRef
Riesgo residual. Conclusiones
Ángel Cequier, José Luis Zamorano
Revista Española de Cardiología Suplementos.2023; 23: 25. CrossRef
Causal effects of circulating lipids and lipid-lowering drugs on the risk of urinary stones: a Mendelian randomization study
Zilong Tan, Jing Hong, Aochuan Sun, Mengdi Ding, Jianwu Shen
Frontiers in Endocrinology.2023;[Epub] CrossRef
Bibliometric analysis of residual cardiovascular risk: trends and frontiers
Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
Journal of Health, Population and Nutrition.2023;[Epub] CrossRef
Current Understanding on the Genetic Basis of Key Metabolic Disorders: A Review
Kenneth Francis Rodrigues, Wilson Thau Lym Yong, Md. Safiul Alam Bhuiyan, Shafiquzzaman Siddiquee, Muhammad Dawood Shah, Balu Alagar Venmathi Maran
Biology.2022; 11(9): 1308. CrossRef
Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
Joon Ho Moon, Kyuho Kim, Sung Hee Choi
Endocrinology and Metabolism.2022; 37(4): 575. CrossRef

Original Article

Metabolic Risk/Epidemiology
Current Status of Low-Density Lipoprotein Cholesterol Target Achievement in Patients with Type 2 Diabetes Mellitus in Korea Compared with Recent Guidelines: Soo Jin Yun, In-Kyung Jeong, Jin-Hye Cha, Juneyoung Lee, Ho Chan Cho, Sung Hee Choi, SungWan Chun, Hyun Jeong Jeon, Ho-Cheol Kang, Sang Soo Kim, Seung-Hyun Ko, Gwanpyo Koh, Su Kyoung Kwon, Jae Hyuk Lee, Min Kyong Moon, Junghyun Noh, Cheol-Young Park, Sungrae Kim; Diabetes Metab J. 2022;46(3):464-475. Published online March 3, 2022; DOI: https://doi.org/10.4093/dmj.2021.0088

14,196 View
450 Download
10 Web of Science
15 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
We evaluated the achievement of low-density lipoprotein cholesterol (LDL-C) targets in patients with type 2 diabetes mellitus (T2DM) according to up-to-date Korean Diabetes Association (KDA), European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS), and American Diabetes Association (ADA) guidelines.
Methods
This retrospective cohort study collected electronic medical record data from patients with T2DM (≥20 years) managed by endocrinologists from 15 hospitals in Korea (January to December 2019). Patients were categorized according to guidelines to assess LDL-C target achievement. KDA (2019): Very High-I (atherosclerotic cardiovascular disease [ASCVD]) <70 mg/dL; Very High-II (target organ damage [TOD], or cardiovascular risk factors [CVRFs]) <70 mg/dL; high (others) <100 mg/dL. ESC/EAS (2019): Very High-I (ASCVD): <55 mg/dL; Very High-II (TOD or ≥3-CVRF) <55 mg/dL; high (diabetes ≥10 years without TOD plus any CVRF) <70 mg/dL; moderate (diabetes <10 years without CVRF) <100 mg/dL. ADA (2019): Very High-I (ASCVD); Very High-II (age ≥40+ TOD, or any CVRF), for high intensity statin or statin combined with ezetimibe.
Results
Among 2,000 T2DM patients (mean age 62.6 years; male 55.9%; mean glycosylated hemoglobin 7.2%) ASCVD prevalence was 24.7%. Of 1,455 (72.8%) patients treated with statins, 73.9% received monotherapy. According to KDA guidelines, LDL-C target achievement rates were 55.2% in Very High-I and 34.9% in Very High-II patients. With ESC/EAS guidelines, target attainment rates were 26.6% in Very High-I, 15.7% in Very High-II, and 25.9% in high risk patients. Based on ADA guidelines, most patients (78.9%) were very-high risk; however, only 15.5% received high-intensity statin or combination therapy.
Conclusion
According to current dyslipidemia management guidelines, LDL-C goal achievement remains suboptimal in Korean patients with T2DM.

Citations

Citations to this article as recorded by

Reshaping the cardiovascular continuum in the management of arterial and venous cardiovascular disease: a narrative review
Khadija Hafidh, Melina Vega de Ceniga, Leonardo De Luca, Claudio Borghi
Journal of Comparative Effectiveness Research.2026;[Epub] CrossRef
ROsulord® sAfety for Patients with Dyslipidemia Study: A Non-interventional, Multicenter, Prospective, Observational Study in South Korea
Do Young Kim, Sung Hea Kim, Eung-Ju Kim, Sang-Jin Han, Ji-Yeong Park, Jong-Chan Youn, Hee-Seok Kim, Ji-Eun Jeong, Kyu-Hyung Ryu
Cardiology and Therapy.2025; 14(1): 17. CrossRef
Diabetic Nephropathy: Pathogenesis, Mechanisms, and Therapeutic Strategies
Shivangi Dwivedi, Mukesh Singh Sikarwar
Hormone and Metabolic Research.2025; 57(01): 7. CrossRef
Remnant Cholesterol Levels at Diagnosis May Predict Acute Coronary Syndrome Occurrence During Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
Hyunsue Do, Oh Chan Kwon, Jang Woo Ha, Jihye Chung, Yong-Beom Park, Ji Hye Huh, Sang-Won Lee
Journal of Clinical Medicine.2025; 14(7): 2260. CrossRef
Lipid Control in Patients With Type 2 Diabetes Mellitus: A Continuous Quality Improvement Study
Andreia G Sousa, Daniela de Azevedo, Suzie Leandro, Marta S Ferreira, Tiago A Correia, Mariana Sá, Diana Capela
Cureus.2025;[Epub] CrossRef
Lipid management in individuals with type 2 diabetes mellitus: Analysis of a hospital-based series
João D. Martins, Débora Silveira, Henrique Pina, Inês Manique, Sílvia Guerra, Cristina Valadas
Endocrinología, Diabetes y Nutrición.2025; : 501674. CrossRef
Risk factor control and cardiovascular events in patients with type 2 diabetes mellitus
Do Kyeong Song, Young Sun Hong, Yeon-Ah Sung, Hyejin Lee, Hidetaka Hamasaki
PLOS ONE.2024; 19(2): e0299035. CrossRef
Distinct effects of rosuvastatin and rosuvastatin/ezetimibe on senescence markers of CD8+ T cells in patients with type 2 diabetes mellitus: a randomized controlled trial
Sang-Hyeon Ju, Joung Youl Lim, Minchul Song, Ji Min Kim, Yea Eun Kang, Hyon-Seung Yi, Kyong Hye Joung, Ju Hee Lee, Hyun Jin Kim, Bon Jeong Ku
Frontiers in Endocrinology.2024;[Epub] CrossRef
Monitoring Global Progress in Core Diabetes Control Metrics: Protocol for a Systematic Review of Prevalence (2015–2023)
John McCaffrey, Samira Barbara Jabakhanji, Roopa Mehta, Steven James, Maisoon Mairghani, Dominika Bhatia, Hazel Ní Chonchubhair, Killian Walsh, Barbara Clyne, Edward W. Gregg
HRB Open Research.2024; 7: 27. CrossRef
Real-world evidence evaluation of LDL-C in hospitalized patients: a population-based observational study in the timeframe 2021–2022
Umberto Capece, Chiara Iacomini, Teresa Mezza, Alfredo Cesario, Carlotta Masciocchi, Stefano Patarnello, Andrea Giaccari, Nicoletta Di Giorgi
Lipids in Health and Disease.2024;[Epub] CrossRef
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
Endocrinology and Metabolism.2024; 39(5): 722. CrossRef
Lipid Management in Korean People With Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Journal of Lipid and Atherosclerosis.2023; 12(1): 12. CrossRef
Lipid Management in Korean People with Type 2 Diabetes Mellitus: Korean Diabetes Association and Korean Society of Lipid and Atherosclerosis Consensus Statement
Ye Seul Yang, Hack-Lyoung Kim, Sang-Hyun Kim, Min Kyong Moon
Diabetes & Metabolism Journal.2023; 47(1): 1. CrossRef
Management of Dyslipidemia in Patients with Diabetes Mellitus
Kyung Ae Lee
The Journal of Korean Diabetes.2023; 24(3): 111. CrossRef
Association between carotid atherosclerosis and presence of intracranial atherosclerosis using three-dimensional high-resolution vessel wall magnetic resonance imaging in asymptomatic patients with type 2 diabetes
Ji Eun Jun, You-Cheol Hwang, Kyu Jeong Ahn, Ho Yeon Chung, Geon-Ho Jahng, Soonchan Park, In-Kyung Jeong, Chang-Woo Ryu
Diabetes Research and Clinical Practice.2022; 191: 110067. CrossRef

Reviews

Metabolic Risk/Epidemiology
Computed Tomography-Derived Myosteatosis and Metabolic Disorders: Iva Miljkovic, Chantal A. Vella, Matthew Allison; Diabetes Metab J. 2021;45(4):482-491. Published online July 30, 2021; DOI: https://doi.org/10.4093/dmj.2020.0277

13,583 View
338 Download
82 Web of Science
82 Crossref

Graphical Abstract Abstract PDF PubReader ePub

The role of ectopic adipose tissue infiltration into skeletal muscle (i.e., myosteatosis) for metabolic disorders has received considerable and increasing attention in the last 10 years. The purpose of this review was to evaluate and summarize existing studies focusing on computed tomography (CT)-derived measures of myosteatosis and metabolic disorders. There is consistent evidence that CT-derived myosteatosis contributes to dysglycemia, insulin resistance, type 2 diabetes mellitus, and inflammation, and, to some extent, dyslipidemia, independent of general obesity, visceral fat, and other relevant risk factors, suggesting that it may serve as a tool for metabolic risk prediction. Identification of which muscles should be examined, and the standardized CT protocols to be employed, are necessary to enhance the applicability of findings from epidemiologic studies of myosteatosis. Additional and longer longitudinal studies are necessary to confirm a role of myosteatosis in the development of type 2 diabetes mellitus, and examine these associations in a variety of muscles across multiple race/ethnic populations. Given the emerging role of myosteatosis in metabolic health, well-designed intervention studies are needed to investigate relevant lifestyle and pharmaceutical approaches.

Citations

Citations to this article as recorded by

Association Between Psoriasis Risk and Body Mass Index and Waist Circumference in Diabetes: A Population-Based Cohort Study
Seungah Yoo, Kyungdo Han, Ji Hyun Lee
Annals of Dermatology.2026; 38(1): 19. CrossRef
Myosteatosis as a metabolic risk in hidradenitis suppurativa: a CT-based study
Didem Didar Balci, Aygün Talibova, Caner Öztürk, Yağız Üstündağ, Raif Can Yarol, Melis Gönülal, Emine Argüz, Melih Özcan, Burçin Kibar Öztürk, Gül Çolakoğlu, Veli Süha Öztürk, Ali Balci
Frontiers in Medicine.2026;[Epub] CrossRef
Muscle quality correlates with hearing thresholds: a cross-sectional analysis
Young-Jee Jeon, Ji Ho Lee, Byung Chul Kang, Joong Keun Kwon
Frontiers in Aging.2026;[Epub] CrossRef
An explainable AI workflow integrating automated volumetric body composition analysis for predicting pathological grading of gastroenteropancreatic neuroendocrine neoplasms: a multicenter cohort study
Chenxi Lyu, Weinuo Qu, Zhibo Wang, Huiyu Gan, Feng Li, Shasha Li, Yaqi Shen, Jiali Li, Zhen Li
International Journal of Surgery.2026;[Epub] CrossRef
Myosteatosis Predicts Bariatric Surgery Response: A Longitudinal Study in Patients With Morbid Obesity
Eugene Han, Mi Kyung Kim, Hye Won Lee, Seungwan Ryu, Hye Soon Kim, Byoung Kuk Jang, Youngsung Suh
The Journal of Clinical Endocrinology & Metabolism.2025; 110(5): e1385. CrossRef
Association of creatinine-to-cystatin C ratio with computed tomography measures of skeletal muscle quantity and quality: The multi-ethnic study of atherosclerosis
Saeid Mirzai, Michael P. Bancks, Tina E. Brinkley, Salvatore Carbone, W. H. Wilson Tang, Matthew A. Allison, Michael D. Shapiro
Clinical Nutrition.2025; 45: 61. CrossRef
Factors associated with trunk skeletal muscle thickness and echo intensity in young Japanese men and women
Funa Kitagawa, Hiroshi Akima, Noriko Ishiguro-Tanaka, Kiyoshi Sanada
PLOS ONE.2025; 20(1): e0312523. CrossRef
Myosteatosis is associated with adiposity, metabolic derangements and mortality in patients with chronic kidney disease
Alice Sabatino, Antonio C. Cordeiro, Carla M. Prado, Bengt Lindholm, Peter Stenvinkel, Carla Maria Avesani
European Journal of Clinical Nutrition.2025; 79(5): 475. CrossRef
Exploring the Relationships between Sex Hormones and Abdominal Muscle Area and Radiodensity in Postmenopausal Women: Insights from the Multi-Ethnic Study of Atherosclerosis
Amar Osmancevic, Matthew Allison, Iva Miljkovic, Chantal A. Vella, Pamela Ouyang, Penelope Trimpou, Bledar Daka
Maturitas.2025; 194: 108197. CrossRef
Poor muscle quality: A hidden and detrimental health condition in obesity
Flavio T. Vieira, Yuanjun Cai, M. Cristina Gonzalez, Bret H. Goodpaster, Carla M. Prado, Andrea M. Haqq
Reviews in Endocrine and Metabolic Disorders.2025; 26(5): 723. CrossRef
Fat‐Free Mass: Friend or Foe to Metabolic Health?
Christopher J. Oliver, Mike Climstein, Nedeljka Rosic, Anja Bosy‐Westphal, Grant Tinsley, Stephen Myers
Journal of Cachexia, Sarcopenia and Muscle.2025;[Epub] CrossRef
Abdominal myosteatosis is associated with lower processing speed in a multiethnic cohort of older adults
Brendan L. McNeish, Iva Miljkovic, Matthew A. Allison, Timothy Hughes, Ilya Nasrallah, Eric Terkpertey, Caterina Rosano
Archives of Gerontology and Geriatrics.2025; 133: 105823. CrossRef
Body composition and cardiometabolic risks of patients with adrenal tumours in relation to hormonal activity: a large cross-sectional single-centre study
Jung Hee Kim, Han Na Jang, Seung Shin Park, Jeong Hee Yoon, Young Min Cho, Sang Joon Park, Jeong Min Lee, Ji Won Yoon
European Journal of Endocrinology.2025; 192(2): 141. CrossRef
Segmentation guided dual-branch classification for measuring fat infiltration in paraspinal muscles
Chengnan Jing, Hao Jiang, Yiheng Li, Qing Liu, Jimin Xiao, Siyue Yu, Minfeng Gan
Expert Systems with Applications.2025; 278: 127260. CrossRef
Fully volumetric body composition analysis for prognostic overall survival stratification in melanoma patients
Katarzyna Borys, Georg Lodde, Elisabeth Livingstone, Carsten Weishaupt, Christian Römer, Marc-David Künnemann, Anne Helfen, Lisa Zimmer, Wolfgang Galetzka, Johannes Haubold, Christoph M. Friedrich, Lale Umutlu, Walter Heindel, Dirk Schadendorf, René Hosch
Journal of Translational Medicine.2025;[Epub] CrossRef
A Nomogram Incorporating Intermuscular Adipose Tissue to Predict Chemotherapy Toxicity in Older Adults With Early-Stage Breast Cancer
Wen-juan Huang, Han-bing Xie, Lin Zhao, Rui-han Zhou, Shurui Wang, Xin Zhang, Rui-tao Wang, Zexun Duan
Journal of Breast Cancer.2025; 28(3): 125. CrossRef
Plasma proteomic analysis of intermuscular fat links muscle integrity with processing speed in older adults
Toshiko Tanaka, Caterina Rosano, Xiaoning Huang, Qu Tian, Bennett A. Landman, Ann Z. Moore, Iva Miljkovic, Andrew Perry, Sadiya Khan, Ravi Kalhan, John Jeffrey Carr, James G. Terry, Kristine Yaffe, Keenan A. Walker, Julián Candia, Luigi Ferrucci
Alzheimer's & Dementia.2025;[Epub] CrossRef
Sarcopenia as a Risk Factor in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Implantation
Laura Büttner, Annette Aigner, Regina Stegherr, Simon Iseke, Martin Jonczyk, Willie Magnus Lüdemann, Timo Alexander Auer, Federico Collettini, Dirk Schnapauff, Maximilian de Bucourt, Bernhard Gebauer, Dominik Geisel, Georg Böning
Diagnostics.2025; 15(11): 1440. CrossRef
Association between the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and Sarcopenic obesity in U.S. adults: a cross-sectional study
Jiao Liu, Fujue Ji, Jong-Hee Kim
Preventive Medicine Reports.2025; 56: 103151. CrossRef
Role of estimated glucose disposal rate in predicting myosteatosis: Insights from abdominal CT analysis
Myung Jin Kim, Yun Kyung Cho, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung
Nutrition, Metabolism and Cardiovascular Diseases.2025; 35(12): 104225. CrossRef
Muscle-brain crosstalk as a driver of brain health in aging
B. L. McNeish, I. Miljkovic, T. Liu-Ambrose, F. Ambrosio, K. Esser, M. Fahnestock, C. Rosano
GeroScience.2025;[Epub] CrossRef
Preoperative myosteatosis and intermuscular adiposity as CT-Derived nutritional prognostic markers in colorectal cancer: A multicenter development-validation study
Yinghao Cao, Yixin Heng, Mingming Song, Tong Nie, Zhihao Liu, Jiaxin Xu, Xiaoyu Wu, Le Qin, Tao Liu, Feihong Wu, Chuansheng Zheng, Kailin Cai
Clinical Nutrition.2025; 53: 8. CrossRef
Abdominal skeletal muscle quality and quantity are independently and jointly associated with cardiometabolic health in children
Emiliano Miranda-Ferrua, Cristina Cadenas-Sanchez, María Medrano, Jonatan R. Ruiz, Fernando Idoate, Maddi Osés, Mara Concepción, Rafael Cabeza, Idoia Labayen
International Journal of Obesity.2025; 49(12): 2511. CrossRef
Association between estimated total skeletal muscle mass and cognitive function in older adults
Ruonan Gao, Zhaorong Lin, Guanlian He, Qintao Huang, Xi He, Jingze Huang, Fei Shao, Lijing Wang, Libin Liu
Geriatric Nursing.2025; 66: 103615. CrossRef
Age-related change in skeletal muscle strength, size, and adiposity over 18 years in Caribbean men
Lauren S. Roe, Ryan K. Cvejkus, Victor W. Wheeler, Christopher L. Gordon, Tanya S. Kenkre, Joseph M. Zmuda, Iva Miljkovic
GeroScience.2025;[Epub] CrossRef
Skeletal muscle adiposity and cognitive decline in a biracial cohort: Insights from coronary artery risk development in young adults (CARDIA) study
Adrianna I. Acevedo‐Fontánez, Caterina Rosano, Kristine Yaffe, J. Jeffrey Carr, James G. Terry, Sangeeta Nair, Emma Barinas‐Mitchell, Ryan K. Cvejkus, Iva Miljkovic
Alzheimer's & Dementia.2025;[Epub] CrossRef
The Influence of Glucagon-like Peptide-1 Receptor Agonists and Other Incretin Hormone Agonists on Body Composition
Lampros Chrysavgis, Niki Gerasimoula Mourelatou, Maria-Evangelia Koloutsou, Sophia Rozani, Evangelos Cholongitas
International Journal of Molecular Sciences.2025; 26(24): 12130. CrossRef
Association of Muscle Fat Content and Muscle Mass With Impaired Lung Function in Young Adults With Obesity: Evaluation With MRI
Xin Yu, Yan-Hao Huang, You-Zhen Feng, Zhong-Yuan Cheng, Cun-Chuan Wang, Xiang-Ran Cai
Academic Radiology.2024; 31(1): 9. CrossRef
Evaluating the efficacy of immunotherapy in gastric cancer: Insights from immune checkpoint inhibitors
Yu-Nuo Yang, Li-Sheng Wang, Yan-Qi Dang, Guang Ji
World Journal of Gastroenterology.2024; 30(32): 3726. CrossRef
Skeletal muscle alterations indicate poor prognosis in cirrhotic patients: a multicenter cohort study in China
Xin Zeng, Zhi-Wen Shi, Jia-Jun Yu, Li-Fen Wang, Chun-Yan Sun, Yuan-Yuan Luo, Pei-Mei Shi, Yong Lin, Yue-Xiang Chen, Jia Guo, Chun-Qing Zhang, Wei-Fen Xie
Hepatology International.2024; 18(2): 673. CrossRef
Subtype-specific Body Composition and Metabolic Risk in Patients With Primary Aldosteronism
Seung Shin Park, Chang Ho Ahn, Sang Wan Kim, Ji Won Yoon, Jung Hee Kim
The Journal of Clinical Endocrinology & Metabolism.2024; 109(2): e788. CrossRef
Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn’s Disease
Mark Donnelly, Dorothee Driever, Éanna J Ryan, Jessie A Elliott, John Finnegan, Deirdre McNamara, Ian Murphy, Kevin C Conlon, Paul C Neary, Dara O Kavanagh, James M O’Riordan
Inflammatory Bowel Diseases.2024; 30(9): 1517. CrossRef
Myosteatosis as a novel predictor of new‐onset diabetes mellitus after kidney transplantation
Takahito Wakamiya, Takuya Fujimoto, Takahito Endo, Shun Nishioka, Naoki Yokoyama, Shimpei Yamashita, Kazuro Kikkawa, Yoji Hyodo, Takeshi Ishimura, Yasuo Kohjimoto, Isao Hara, Masato Fujisawa
International Journal of Urology.2024; 31(1): 39. CrossRef
Predictors of visceral and subcutaneous adipose tissue and muscle density: The ShapeUp! Kids study
Gertraud Maskarinec, Yurii Shvetsov, Michael C. Wong, Devon Cataldi, Jonathan Bennett, Andrea K. Garber, Steven D. Buchthal, Steven B. Heymsfield, John A. Shepherd
Nutrition, Metabolism and Cardiovascular Diseases.2024; 34(3): 799. CrossRef
Association of daily carbohydrate intake with intermuscular adipose tissue in Korean individuals with obesity: a cross-sectional study
Ha-Neul Choi, Young-Seol Kim, Jung-Eun Yim
Nutrition Research and Practice.2024; 18(1): 78. CrossRef
Myosteatosis is associated with poor survival after kidney transplantation: a large retrospective cohort validation
Jie Chen, Yue Li, Chengjie Li, Turun Song
Abdominal Radiology.2024; 49(4): 1210. CrossRef
Regenerative rehabilitation measures to restore tissue function after arsenic exposure
Adam A. Jasper, Kush H. Shah, Helmet Karim, Swathi Gujral, Iva Miljkovic, Caterina Rosano, Aaron Barchowsky, Amrita Sahu
Current Opinion in Biomedical Engineering.2024; 30: 100529. CrossRef
Impact of CFTR modulator therapy on body composition as assessed by thoracic computed tomography: A follow-up study
Víctor Navas-Moreno, Fernando Sebastian-Valles, Víctor Rodríguez-Laval, Carolina Knott-Torcal, Mónica Marazuela, Nuria Sánchez de la Blanca, Jose Alfonso Arranz Martín, Rosa María Girón, Miguel Antonio Sampedro-Núñez
Nutrition.2024; 123: 112425. CrossRef
Myosteatosis predicts postoperative complications and long‐term survival in robotic gastrectomy for gastric cancer: A propensity score analysis
Pingan Ding, Jiaxiang Wu, Haotian Wu, Tongkun Li, Jiaxuan Yang, Li Yang, Honghai Guo, Yuan Tian, Peigang Yang, Lingjiao Meng, Qun Zhao
European Journal of Clinical Investigation.2024;[Epub] CrossRef
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence
Eunhye Seo, Yeongkeun Kwon, Ahmad ALRomi, Mohannad Eledreesi, Sungsoo Park
Reviews in Endocrine and Metabolic Disorders.2024; 25(4): 677. CrossRef
Muscle Steatosis and Fibrosis in Older Adults, From the AJR Special Series on Imaging of Fibrosis
Leon Lenchik, Valentina Mazzoli, Peggy M. Cawthon, Russell T. Hepple, Robert D. Boutin
American Journal of Roentgenology.2024;[Epub] CrossRef
Prognostic impact of myosteatosis in patients with colorectal cancer undergoing curative surgery: an updated systematic review and meta-analysis
Yu-Yao Chang, Bill Cheng
Frontiers in Oncology.2024;[Epub] CrossRef
Levels of Sex Hormones and Abdominal Muscle Composition in Men from The Multi-Ethnic Study of Atherosclerosis
Amar Osmancevic, Matthew Allison, Iva Miljkovic, Chantal A. Vella, Pamela Ouyang, Penelope Trimpou, Bledar Daka
Scientific Reports.2024;[Epub] CrossRef
Association between atherogenic dyslipidemia and muscle quality defined by myosteatosis
Hwi Seung Kim, Yun Kyung Cho, Myung Jin Kim, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung
Frontiers in Endocrinology.2024;[Epub] CrossRef
Lower skeletal muscle density and airway structure on computed tomography in asthma
Yusuke Hayashi, Naoya Tanabe, Kaoruko Shimizu, Tomoki Maetani, Yusuke Shiraishi, Tsuyoshi Oguma, Hironobu Sunadome, Ryo Sakamoto, Atsuyasu Sato, Susumu Sato, Hiroshi Date, Hisako Matsumoto, Toyohiro Hirai
Annals of Allergy, Asthma & Immunology.2024; 133(6): 667. CrossRef
Patients With Type 2 Diabetes Mellitus and Early Diabetic Kidney Disease Exhibit Lower Computed Tomography-measured Skeletal Muscle Attenuation Values: A Propensity Score-matched Study
Jinlei Fan, Liping Zuo, Fangxuan Li, Bowen Wang, Yueming An, Dexin Yu
Journal of Renal Nutrition.2024; 34(6): 509. CrossRef
Steatosarcopenia: A New Terminology for Clinical Conditions Related to Body Composition Classification
Glaycon Michels, Guido Mattos Rosa, Guilherme Renke, Bernardo Starling-Soares
Life.2024; 14(11): 1383. CrossRef
The Role of Frailty and Myosteatosis in Predicting All-Cause Mortality in Older Adults with Cancer
Efthymios Papadopoulos, Andy Kin On Wong, Sharon Hiu Ching Law, Sarah Costa, Angela M. Cheung, Dmitry Rozenberg, Shabbir M. H. Alibhai
Current Oncology.2024; 31(12): 7852. CrossRef
Clinical Application of Artificial Intelligence-Based Computed Tomography Analysis of Myosteatosis in Localized Renal Cell Carcinoma
Byeong Jin Kang, Kyung Hwan Kim, Seung Baek Hong, Nam Kyung Lee, Suk Kim, Sihwan Kim, Hong Koo Ha
Journal of Urologic Oncology.2024; 22(3): 237. CrossRef
Effects of a One-Year Intensified Weight Loss Program on Body Composition Parameters in Patients with Severe Obesity and Obstructive Sleep Apnea (OSA): A Randomized Controlled Trial
Laia Miralles-Llumà, Nuria Vilarrasa, Carmen Monasterio, Carla López-Padrós, Carolina Alves, Rosa Planas, Lorena Arribas, Monica Montserrat, Sandra Pérez-Ramos, Natàlia Pallarès, Neus Salord
Nutrients.2024; 16(24): 4255. CrossRef
Body Composition at CT and Risk of Future Disease
Michael A. Ohliger
Radiology.2023;[Epub] CrossRef
Association between hypertension and myosteatosis evaluated by abdominal computed tomography
Han Na Jung, Yun Kyung Cho, Hwi Seung Kim, Eun Hee Kim, Min Jung Lee, Woo Je Lee, Hong-Kyu Kim, Chang Hee Jung
Hypertension Research.2023; 46(4): 845. CrossRef
Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia
Carla Maria Avesani, Aline Miroski de Abreu, Heitor S. Ribeiro, Torkel B. Brismar, Peter Stenvinkel, Alice Sabatino, Bengt Lindholm
Journal of Nephrology.2023; 36(3): 895. CrossRef
Myosteatosis: a potential missing link between hypertension and metabolic disorder in the Asian population
Minyoung Lee, Sungha Park
Hypertension Research.2023; 46(6): 1603. CrossRef
Interplay of skeletal muscle and adipose tissue: sarcopenic obesity
Min Jeong Park, Kyung Mook Choi
Metabolism.2023; 144: 155577. CrossRef
Association between sarcopenic obesity and poor muscle quality based on muscle quality map and abdominal computed tomography
Yun Kyung Cho, Han Na Jung, Eun Hee Kim, Min Jung Lee, Joong‐Yeol Park, Woo Je Lee, Hong‐Kyu Kim, Chang Hee Jung
Obesity.2023; 31(6): 1547. CrossRef
Chest CT opportunistic biomarkers for phenotyping high-risk COVID-19 patients: a retrospective multicentre study
Anna Palmisano, Chiara Gnasso, Alberto Cereda, Davide Vignale, Riccardo Leone, Valeria Nicoletti, Simone Barbieri, Marco Toselli, Francesco Giannini, Marco Loffi, Gianluigi Patelli, Alberto Monello, Gianmarco Iannopollo, Davide Ippolito, Elisabetta Maria
European Radiology.2023; 33(11): 7756. CrossRef
Early menopause and premature ovarian insufficiency may increase the risk of sarcopenia: A systematic review and meta-analysis
Efstathios Divaris, Panagiotis Anagnostis, Nifon K. Gkekas, Evangelia Kouidi, Dimitrios G. Goulis
Maturitas.2023; 175: 107782. CrossRef
The Important Role of Intermuscular Adipose Tissue on Metabolic Changes Interconnecting Obesity, Ageing and Exercise: A Systematic Review
I Gusti Putu Suka Aryana, Ivana Beatrice Paulus, Sanjay Kalra, Dian Daniella, Raden Ayu Tuty Kuswardhani, Ketut Suastika, Sony Wibisono
European Endocrinology.2023; 19(1): 54. CrossRef
Increase in skeletal muscular adiposity and cognitive decline in a biracial cohort of older men and women
Caterina Rosano, Anne Newman, Adam Santanasto, Xiaonan Zhu, Bret Goodpaster, Iva Miljkovic
Journal of the American Geriatrics Society.2023; 71(9): 2759. CrossRef
Myosteatosis and bone marrow adiposity are not associated among postmenopausal women with fragility fractures
Sammy Badr, Héloïse Dapvril, Daniela Lombardo, Huda Khizindar, Claire Martin, Bernard Cortet, Anne Cotten, Julien Paccou
Frontiers in Endocrinology.2023;[Epub] CrossRef
Relationship between trunk intramuscular adipose tissue content and prevalence of metabolic syndrome in middle-aged Japanese men
Noriko I. Tanaka, Masataka Suwa, Hisashi Maeda, Aya Tomita, Takayuki Imoto, Hiroshi Akima
Nutrition.2023; 113: 112083. CrossRef
Sarcopenic obesity and its relation with muscle quality and mortality in patients on chronic hemodialysis
Alice Sabatino, Carla Maria Avesani, Giuseppe Regolisti, Marianna Adinolfi, Giuseppe Benigno, Marco Delsante, Enrico Fiaccadori, Ilaria Gandolfini
Clinical Nutrition.2023; 42(8): 1359. CrossRef
Skeletal muscle adiposity is a novel risk factor for poor cognition in African Caribbean women
Adrianna I. Acevedo‐Fontánez, Ryan K. Cvejkus, Joseph M. Zmuda, Allison L. Kuipers, Emma Barinas‐Mitchell, Akira Sekikawa, Victor Wheeler, Caterina Rosano, Iva Miljkovic
Obesity.2023; 31(9): 2398. CrossRef
Meld-sarcopenia score and skeletal muscle density predicts short-term readmission of patients with hepatic encephalopathy
Shuo Yang, Lin Zhang, Qian Jin, Jian Wang, Danli Ma, Jie Gao, Rui Huang
European Journal of Radiology.2023; 169: 111178. CrossRef
Muscle Fat Content Is Associated with Nonalcoholic Fatty Liver Disease and Liver Fibrosis in Chinese Adults
W. Guo, X. Zhao, D. Cheng, X. Liang, M. Miao, X. Li, J. Lu, N. Xu, Shuang Hu, Qun Zhang
The Journal of nutrition, health and aging.2023; 27(11): 960. CrossRef
Association between relative muscle strength and hypertension in middle-aged and older Chinese adults
Jin-hua Luo, Tu-ming Zhang, Lin-lin Yang, Yu-ying Cai, Yu Yang
BMC Public Health.2023;[Epub] CrossRef
Dynapenic Abdominal Obesity as a Risk Factor for Metabolic Syndrome in Individual 50 Years of Age or Older: English Longitudinal Study of Ageing
P.C. Ramírez, R. de Oliveira Máximo, D. Capra de Oliveira, A.F. de Souza, M. Marques Luiz, M. L. Bicigo Delinocente, A. Steptoe, C. de Oliveira, Tiago da Silva Alexandre
The Journal of nutrition, health and aging.2023; 27(12): 1188. CrossRef
Editorial Comment to Myosteatosis as a novel predictor of urinary incontinence after robot‐assisted radical prostatectomy
Nobuhiro Haga, Naotaka Gunge, Hiroshi Matsuzaki, Yu Okabe, Takeshi Miyazaki
International Journal of Urology.2022; 29(1): 40. CrossRef
Ammonia and the Muscle: An Emerging Point of View on Hepatic Encephalopathy
Simone Di Cola, Silvia Nardelli, Lorenzo Ridola, Stefania Gioia, Oliviero Riggio, Manuela Merli
Journal of Clinical Medicine.2022; 11(3): 611. CrossRef
Single skeletal muscle fiber mechanical properties: a muscle quality biomarker of human aging
Jae-Young Lim, Walter R. Frontera
European Journal of Applied Physiology.2022; 122(6): 1383. CrossRef
Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement
Jiacheng Liu, Jinqiang Ma, Chongtu Yang, Manman Chen, Qin Shi, Chen Zhou, Songjiang Huang, Yang Chen, Yingliang Wang, Tongqiang Li, Bin Xiong
Radiology.2022; 303(3): 711. CrossRef
Myosteatosis Significantly Predicts Persistent Dyspnea and Mobility Problems in COVID-19 Survivors
Rebecca De Lorenzo, Anna Palmisano, Antonio Esposito, Chiara Gnasso, Valeria Nicoletti, Riccardo Leone, Davide Vignale, Elisabetta Falbo, Marica Ferrante, Marta Cilla, Cristiano Magnaghi, Sabina Martinenghi, Giordano Vitali, Alessio Molfino, Patrizia Rove
Frontiers in Nutrition.2022;[Epub] CrossRef
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis
Shaofang Feng, Huiwen Mu, Rong Hou, Yunxin Liu, Jianjun Zou, Zheng Zhao, Yubing Zhu
International Journal of Clinical Oncology.2022; 27(7): 1127. CrossRef
Muscle Fat Content Is Strongly Associated With Hyperuricemia: A Cross-Sectional Study in Chinese Adults
Ningxin Chen, Tingting Han, Hongxia Liu, Jie Cao, Wenwen Liu, Didi Zuo, Ting Zhang, Xiucai Lan, Xian Jin, Yurong Weng, Yaomin Hu
Frontiers in Endocrinology.2022;[Epub] CrossRef
Advances in muscle health and nutrition: A toolkit for healthcare professionals
Carla M. Prado, Francesco Landi, Samuel T.H. Chew, Philip J. Atherton, Jeroen Molinger, Tobias Ruck, Maria Cristina Gonzalez
Clinical Nutrition.2022; 41(10): 2244. CrossRef
Factors related to trunk intramuscular adipose tissue content – A comparison of younger and older men
Funa Kitagawa, Madoka Ogawa, Akito Yoshiko, Yoshiharu Oshida, Teruhiko Koike, Hiroshi Akima, Noriko I. Tanaka
Experimental Gerontology.2022; 168: 111922. CrossRef
Association of myosteatosis with various body composition abnormalities and longer length of hospitalization in patients with decompensated cirrhosis
Xiaoyu Wang, Mingyu Sun, Yifan Li, Gaoyue Guo, Wanting Yang, Lihong Mao, Zihan Yu, Yangyang Hui, Xiaofei Fan, Binxin Cui, Kui Jiang, Chao Sun
Frontiers in Nutrition.2022;[Epub] CrossRef
Peripheral bone structure, geometry, and strength and muscle density as derived from peripheral quantitative computed tomography and mortality among rural south Indian older adults
Guru Rajesh Jammy, Robert M. Boudreau, Iva Miljkovic, Pawan Kumar Sharma, Sudhakar Pesara Reddy, Susan L. Greenspan, Anne B. Newman, Jane A. Cauley, Bert B. Little
PLOS Global Public Health.2022; 2(10): e0000333. CrossRef
Muscle fat contents rather than muscle mass determines nonalcoholic steatohepatitis and liver fibrosis in patients with severe obesity
Eugene Han, Mi Kyung Kim, Hye Won Lee, Seungwan Ryu, Hye Soon Kim, Byoung Kuk Jang, Youngsung Suh
Obesity.2022; 30(12): 2440. CrossRef
Sex- and region-specific associations of skeletal muscle mass with metabolic dysfunction-associated fatty liver disease
Pei Xiao, Pu Liang, Panjun Gao, Jinyi Wu
Frontiers in Endocrinology.2022;[Epub] CrossRef
Imaging based body composition profiling and outcomes after oncologic liver surgery
Lorenzo Bernardi, Raffaello Roesel, Filippo Vagelli, Pietro Majno-Hurst, Alessandra Cristaudi
Frontiers in Oncology.2022;[Epub] CrossRef

Drug/Regimen
Fibrates Revisited: Potential Role in Cardiovascular Risk Reduction: Nam Hoon Kim, Sin Gon Kim; Diabetes Metab J. 2020;44(2):213-221. Published online April 23, 2020; DOI: https://doi.org/10.4093/dmj.2020.0001

17,555 View
448 Download
64 Web of Science
70 Crossref

Abstract PDF PubReader ePub

Fibrates, peroxisome proliferator-activated receptor-α agonists, are potent lipid-modifying drugs. Their main effects are reduction of triglycerides and increase in high-density lipoprotein levels. Several randomized controlled trials have not demonstrated their benefits on cardiovascular risk reduction, especially as an “add on” to statin therapy. However, subsequent analyses by major clinical trials, meta-analyses, and real-world evidence have proposed their potential in specific patient populations with atherogenic dyslipidemia and metabolic syndrome. Here, we have reviewed and discussed the accumulated data on fibrates to understand their current status in cardiovascular risk management.

Citations

Citations to this article as recorded by

Continuous Flow Technologies for the Synthesis of Pharmaceutically and Biologically Important Molecules: Update and Analysis
Yu‐kun Zhang, Eman Fayad, Dalal Nasser Binjawhar, Bing Sun, Hua‐Li Qin
ChemistrySelect.2026;[Epub] CrossRef
Apolipoprotein B-containing lipoproteins in atherogenesis
Jan Borén, Chris J. Packard, Christoph J. Binder
Nature Reviews Cardiology.2025; 22(6): 399. CrossRef
Effect of Fibrates on Lipoprotein-associated Phospholipase A2 Mass and Activity: A Systematic Review and Meta-analysis of Controlled Clinical Trials
Luis E. Simental-Mendia, Mario Simental-Mendía, Claudia I. Gamboa-Gomez, Tannaz Jamialahmadi, Amirhossein Sahebkar
Current Pharmaceutical Design.2025; 31(15): 1205. CrossRef
Fatty acid binding proteins-mediated mitochondrial dysfunction in the development of age-related diseases: A review
Xingxing Ren, Chaoyuan Jin, Qilin Li, Congyi Fu, Yu Fang, Zihang Xu, Zi Liang, Tianshi Wang
International Journal of Biological Macromolecules.2025; 309: 142913. CrossRef
An update on renal tubular injury as related to glycolipid metabolism in diabetic kidney disease
Anqi Feng, Ruili Yin, Rong Xu, Baoyu Zhang, Longyan Yang
Frontiers in Pharmacology.2025;[Epub] CrossRef
Novel carboxamide derivatives increase lipoprotein lipase gene expression in endothelial and adipose tissues of triton WR- 1339 induced hyperlipidemic rats
Suhair Hikmat, Aya Hasan, Lama Hamadneh, Mohammad Alwahsh, Sameer Al-Kouz, Yusuf Al-Hiari, Basmah Al-Jammal, Tariq Al-Qirim, Buthaina Hussein
Naunyn-Schmiedeberg's Archives of Pharmacology.2025; 398(10): 14315. CrossRef
The approach to triglyceride levels in patients with coronary heart disease
Ilay Shani, Avishay Elis
European Journal of Internal Medicine.2025; 139: 106375. CrossRef
Effect of adding fenofibrate versus curcumin to glimepiride in patients with type 2 diabetes: a randomized controlled trial
Eman M. Nada, Nashwa M. El-Gharbawy, Haidy Abbas, Rehab H. Werida
BMC Pharmacology and Toxicology.2025;[Epub] CrossRef
Effects of fibrates on lipid profile: a meta-analysis of randomized controlled trials
Elena Olmastroni, Federica Galimberti, Sining Xie, Manuela Casula, Alberico L Catapano
European Atherosclerosis Journal.2025;[Epub] CrossRef
Hypertriglyceridemia (triglyceride-rich lipoproteins and their remnants): role in the development of atherosclerotic cardiovascular diseases and control strategy. Opinion of the Expert Committee of the Russian Society of Cardiology, the National Atheroscl
M. G. Bubnova, M. N. Ezhov, D. M. Aronov, A. S. Galyavich, V. S. Gurevich, D. V. Duplyakov, V. K. Zafiraki, N. S. Karamnova, V. V. Kashtalap, G. A. Konovalov, A. N Meshkov, A. G. Obrezan, A. A. Semenkin, I. V. Sergienko, A. E. Filippov
Russian Journal of Cardiology.2025; 30(5): 6364. CrossRef
Chemical Synthesis, Biological Evaluation, and Cheminformatics Analysis of a Group of Chlorinated Diaryl Sulfonamides: Promising Inhibitors of Cholesteryl Ester Transfer Protein
Reema Abu Khalaf, Ala’a Lafi, Rima Hajjo, Mahmoud A. Al-Sha'er
Current Computer-Aided Drug Design.2025; 21(5): 694. CrossRef
Characterizing Fenofibrate-Related Renal and Urinary Adverse Events: A Comprehensive Analysis of FDA Adverse Event Reporting System Database
Li Wang, Xiangyun Jin, YanChun Li
Clinical Therapeutics.2025; 47(12): 1149. CrossRef
Hypertriglyceridemia (triglyceride-rich lipoproteins and their remnants): role in development of atherosclerotic cardiovascular diseases and control strategy consensus statement of the expert Committee of the Russian Society of Cardiology (RSC), the Natio
Marina G. Bubnova, Marat V. Ezhov, David M. Aronov, Albert S. Galyаvich, Viktor S. Gurevich, Dmitry V. Duplyakov, Vitaliy K. Zafiraki, Natalia S. Karamnova, Vasily V. Kashtalap, Gennady A. Konovalov, Alexey N. Meshkov, Andrey G. Obrezan, Alexander A. Seme
CardioSomatics.2025; 16(3): 192. CrossRef
2025: The year in cardiovascular disease – the year of triglyceride lowering therapies. Can we effectively reduce triglyceride-related residual cardiovascular disease and pancreatitis risk?
Peter P. Toth, Maciej Banach
Archives of Medical Science.2025; 21(6): 2229. CrossRef
Associations of omega-3 fatty acids vs. fenofibrate with adverse cardiovascular outcomes in people with metabolic syndrome: propensity matched cohort study
Nam Hoon Kim, Ji Yoon Kim, Jimi Choi, Sin Gon Kim
European Heart Journal - Cardiovascular Pharmacotherapy.2024; 10(2): 118. CrossRef
Role of PPARα in inflammatory response of C2C12 myotubes
Yuki Shimizu, Keiko Hamada, Tingting Guo, Chie Hasegawa, Yusuke Kuga, Katsushi Takeda, Takashi Yagi, Hiroyuki Koyama, Hiroshi Takagi, Daisuke Aotani, Hiromi Kataoka, Tomohiro Tanaka
Biochemical and Biophysical Research Communications.2024; 694: 149413. CrossRef
Obicetrapib: Reversing the Tide of CETP Inhibitor Disappointments
John J. P. Kastelein, Andrew Hsieh, Mary R. Dicklin, Marc Ditmarsch, Michael H. Davidson
Current Atherosclerosis Reports.2024; 26(2): 35. CrossRef
Metabolic Flexibility of the Heart: The Role of Fatty Acid Metabolism in Health, Heart Failure, and Cardiometabolic Diseases
Virginia Actis Dato, Stephan Lange, Yoshitake Cho
International Journal of Molecular Sciences.2024; 25(2): 1211. CrossRef
ApoB100 and Atherosclerosis: What’s New in the 21st Century?
Dimitris Kounatidis, Natalia G. Vallianou, Aikaterini Poulaki, Angelos Evangelopoulos, Fotis Panagopoulos, Theodora Stratigou, Eleni Geladari, Irene Karampela, Maria Dalamaga
Metabolites.2024; 14(2): 123. CrossRef
Follistatin-like 1 (FSTL1) levels as potential early biomarker of cardiovascular disease in a Mexican population
N. Ponce-Ruíz, J. F. Herrera-Moreno, A. E. Rojas-García, B. S. Barrón-Vivanco, C. A. González-Arias, Y. Y. Bernal-Hernández, L. Ortega-Cervantes, J. Ponce-Gallegos, J. A. Hernández-Nolasco, I. M. Medina-Díaz
Heart and Vessels.2024; 39(6): 563. CrossRef
Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
Chaicharn Deerochanawong, Sin Gon Kim, Yu-Cheng Chang
Diabetes & Metabolism Journal.2024; 48(2): 184. CrossRef
Coenzyme Q10 in atherosclerosis
Minjun Liao, Xueke He, Yangyang Zhou, Weiqiang Peng, Xiao-Mei Zhao, Miao Jiang
European Journal of Pharmacology.2024; 970: 176481. CrossRef
Onion Polyphenols as Multi-Target-Directed Ligands in MASLD: A Preliminary Molecular Docking Study
Maria Paravati, Anna Procopio, Maja Milanović, Giuseppe Scarlata, Nataša Milošević, Maja Ružić, Nataša Milić, Ludovico Abenavoli
Nutrients.2024; 16(8): 1226. CrossRef
Therapeutic approach in the treatment of dyslipidemia: Novelties and challenges
Katarina Lalić, Nataša Rajković, Ljiljana Popović, Sandra Singh-Lukač, Iva Rasulić, Ana Petakov, Milica Krstić, Marija Mitrović
Galenika Medical Journal.2024; 3(9): 31. CrossRef
Research trends in lipid-lowering therapies for coronary heart disease combined with hyperlipidemia: a bibliometric study and visual analysis
Quankai Cheng, Jingjing Sun, Haicheng Zhong, Ziming Wang, Chang Liu, Sheng Zhou, Jie Deng
Frontiers in Pharmacology.2024;[Epub] CrossRef
Expression of FAM159B in Humans, Rats, and Mice: A Cross-species Examination
Anna-Sophia Liselott Beyer, Daniel Kaemmerer, Jörg Sänger, Amelie Lupp
Journal of Histochemistry & Cytochemistry.2024; 72(7): 467. CrossRef
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies
Dimitris Kounatidis, Nikolaos Tentolouris, Natalia G. Vallianou, Iordanis Mourouzis, Irene Karampela, Theodora Stratigou, Eleni Rebelos, Marina Kouveletsou, Vasileios Stamatopoulos, Eleni Tsaroucha, Maria Dalamaga
Metabolites.2024; 14(7): 388. CrossRef
Fenofibrate’s impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study
Sangmo Hong, Kyung-Soo Kim, Kyungdo Han, Cheol-Young Park
Cardiovascular Diabetology.2024;[Epub] CrossRef
The role of DGAT1 and DGAT2 in tumor progression via fatty acid metabolism: A comprehensive review
Leisheng Wang, Shiwei Xu, Mengzhen Zhou, Hao Hu, Jinyou Li
International Journal of Biological Macromolecules.2024; 278: 134835. CrossRef
Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factor
Nam Hoon Kim, Juneyoung Lee, Suk Chon, Jae Myung Yu, In-Kyung Jeong, Soo Lim, Won Jun Kim, Keeho Song, Ho Chan Cho, Hea Min Yu, Kyoung-Ah Kim, Sang Soo Kim, Soon Hee Lee, Chong Hwa Kim, Soo Heon Kwak, Yong‐ho Lee, Choon Hee Chung, Sihoon Lee, Heung Yong J
Endocrinology and Metabolism.2024; 39(5): 722. CrossRef
Safety and Efficacy of the Novel RNA Interference Therapies for Hypertriglyceridemia and Mixed Hyperlipidemia Management: A Systematic Review and Meta-analysis
A.B.M. Kamrul-Hasan, Deep Dutta, Lakshmi Nagendra, Sunetra Mondal, Saptarshi Bhattacharya, Sanjay Kalra
Endocrine Practice.2024; 30(11): 1103. CrossRef
Effects of Fatty Acid Metabolism on Heart Failure
日娜萨
Advances in Clinical Medicine.2024; 14(09): 787. CrossRef
Revisiting PPAR agonists: novel perspectives in the treatment of primary biliary cholangitis
Yiran Chen, Kunyu Zheng, Gahu Da, Xu Wang, Yi Wei, Guochun Wang, Fengchun Zhang, Li Wang
Expert Opinion on Pharmacotherapy.2024; 25(13): 1825. CrossRef
Integrated review of cardiometabolic biomarkers and dietary nutrients
Ravindra Verma, Prakash S Bisen, Mònica Bulló
Journal of Food Bioactives.2024; : 44. CrossRef
Cardiovascular Diseases and Metabolic Medications in the Lebanese Population: A Post Hoc Analysis from a Nationwide Cross-Sectional Study
Rony M. Zeenny, Rachel Abdo, Chadia Haddad, Aline Hajj, Rouba Karen Zeidan, Pascale Salameh, Jean Ferrieres
Pharmacy.2024; 12(6): 171. CrossRef
From Adipose to Ailing Kidneys: The Role of Lipid Metabolism in Obesity-Related Chronic Kidney Disease
Wenchao Xu, Yuting Zhu, Siyuan Wang, Jihong Liu, Hao Li
Antioxidants.2024; 13(12): 1540. CrossRef
Exploring the mechanism of fibrates regulating HIF-1A in the treatment of ischemic stroke based on network pharmacology and molecular docking
Fengjiao Yang, Zixuan Yang, Ya Yan, Yun Gu, Pengyu Wang, Min Wang, Jianjie Chen, Xiaoshan Du, Guangming Wang
BMC Research Notes.2024;[Epub] CrossRef
Present and Future of Dyslipidaemia Treatment—A Review
Iveta Merćep, Andro Vujević, Dominik Strikić, Ivana Radman, Ivan Pećin, Željko Reiner
Journal of Clinical Medicine.2023; 12(18): 5839. CrossRef
VLDL receptor gene therapy for reducing atherogenic lipoproteins
Ronald M. Krauss, Jonathan T. Lu, Joseph J. Higgins, Cathryn M. Clary, Ray Tabibiazar
Molecular Metabolism.2023; 69: 101685. CrossRef
The emerging role of PPAR-alpha in breast cancer
Zhiwen Qian, Lingyan Chen, Jiayu Liu, Ying Jiang, Yan Zhang
Biomedicine & Pharmacotherapy.2023; 161: 114420. CrossRef
Molecular mechanisms and therapeutic perspectives of peroxisome proliferator‐activated receptor α agonists in cardiovascular health and disease
Yujie Pu, Chak Kwong Cheng, Hongsong Zhang, Jiang‐Yun Luo, Li Wang, Brian Tomlinson, Yu Huang
Medicinal Research Reviews.2023; 43(6): 2086. CrossRef
Macrophage angiotensin-converting enzyme reduces atherosclerosis by increasing peroxisome proliferator-activated receptor α and fundamentally changing lipid metabolism
DuoYao Cao, Zakir Khan, Xiaomo Li, Suguru Saito, Ellen A Bernstein, Aaron R Victor, Faizan Ahmed, Aoi O Hoshi, Luciana C Veiras, Tomohiro Shibata, Mingtian Che, Lei Cai, Michifumi Yamashita, Ryan E Temel, Jorge F Giani, Daniel J Luthringer, Ajit S Divakar
Cardiovascular Research.2023; 119(9): 1825. CrossRef
Rapid flow synthesis of fenofibrate via scalable flash chemistry with in-line Li recovery
Sanket A. Kawale, Dong-Chang Kang, Gwang-Noh Ahn, Amirreza Mottafegh, Ji-Ho Kang, Gi-Su Na, Dong-Pyo Kim
Chemical Engineering Journal.2023; 477: 147033. CrossRef
Effectiveness and Safety of Fenofibrate in Routine Treatment of Patients with Hypertriglyceridemia and Metabolic Syndrome
Marat V. Ezhov, Gregory P. Arutyunov
Diseases.2023; 11(4): 140. CrossRef
Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
Giulio Preta
Cells.2023; 12(20): 2466. CrossRef
Exploring the hypolipidemic effects of bergenin from Saxifraga melanocentra Franch: mechanistic insights and potential for hyperlipidemia treatment
Li Zhang, Yingying Tong, Yan Fang, Jinjin Pei, Qilan Wang, Gang Li
Lipids in Health and Disease.2023;[Epub] CrossRef
Obesity and Dyslipidemia
Barbora Nussbaumerova, Hana Rosolova
Current Atherosclerosis Reports.2023; 25(12): 947. CrossRef
Bibliometric analysis of residual cardiovascular risk: trends and frontiers
Lin Wang, Sutong Wang, Chaoyuan Song, Yiding Yu, Yuehua Jiang, Yongcheng Wang, Xiao Li
Journal of Health, Population and Nutrition.2023;[Epub] CrossRef
Hypertriglyceridemia in Apoa5–/– mice results from reduced amounts of lipoprotein lipase in the capillary lumen
Ye Yang, Anne P. Beigneux, Wenxin Song, Le Phuong Nguyen, Hyesoo Jung, Yiping Tu, Thomas A. Weston, Caitlyn M. Tran, Katherine Xie, Rachel G. Yu, Anh P. Tran, Kazuya Miyashita, Katsuyuki Nakajima, Masami Murakami, Yan Q. Chen, Eugene Y. Zhen, Joonyoung R.
Journal of Clinical Investigation.2023;[Epub] CrossRef
Blood-Derived Lipid and Metabolite Biomarkers in Cardiovascular Research from Clinical Studies: A Recent Update
Dipali Kale, Amol Fatangare, Prasad Phapale, Albert Sickmann
Cells.2023; 12(24): 2796. CrossRef
Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia
Gary F Lewis, Robert A Hegele
The Lancet Diabetes & Endocrinology.2022; 10(2): 142. CrossRef
Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study
Thomas Metzner, Deborah R. Leitner, Karin Mellitzer, Andrea Beck, Harald Sourij, Tatjana Stojakovic, Gernot Reishofer, Winfried März, Ulf Landmesser, Hubert Scharnagl, Hermann Toplak, Günther Silbernagel
Biomedicines.2022; 10(1): 193. CrossRef
Is there a role of lipid-lowering therapies in the management of fatty liver disease?
Ismini Tzanaki, Aris P Agouridis, Michael S Kostapanos
World Journal of Hepatology.2022; 14(1): 119. CrossRef
Therapeutic Strategies and Chemoprevention of Atherosclerosis: What Do We Know and Where Do We Go?
Ana Clara Aprotosoaie, Alexandru-Dan Costache, Irina-Iuliana Costache
Pharmaceutics.2022; 14(4): 722. CrossRef
The Overlooked Transformation Mechanisms of VLCFAs: Peroxisomal β-Oxidation
Qinyue Lu, Weicheng Zong, Mingyixing Zhang, Zhi Chen, Zhangping Yang
Agriculture.2022; 12(7): 947. CrossRef
Current Trends of Big Data Research Using the Korean National Health Information Database
Mee Kyoung Kim, Kyungdo Han, Seung-Hwan Lee
Diabetes & Metabolism Journal.2022; 46(4): 552. CrossRef
New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
Diabetes & Metabolism Journal.2022; 46(4): 517. CrossRef
Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure
Agata Jedrzejewska, Alicja Braczko, Ada Kawecka, Marcin Hellmann, Piotr Siondalski, Ewa Slominska, Barbara Kutryb-Zajac, Magdi H. Yacoub, Ryszard T. Smolenski
International Journal of Molecular Sciences.2022; 23(17): 9886. CrossRef
Lipoprotein Lipase: Is It a Magic Target for the Treatment of Hypertriglyceridemia
Joon Ho Moon, Kyuho Kim, Sung Hee Choi
Endocrinology and Metabolism.2022; 37(4): 575. CrossRef
Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
Metabolism.2022; 137: 155327. CrossRef
Alterations of HDL’s to piHDL’s Proteome in Patients with Chronic Inflammatory Diseases, and HDL-Targeted Therapies
Veronika Vyletelová, Mária Nováková, Ľudmila Pašková
Pharmaceuticals.2022; 15(10): 1278. CrossRef
Cardiovascular Risk Profile and Lipid Management in the Population-Based Cohort Study LATINO: 20 Years of Real-World Data
Cristina Gavina, Daniel Seabra Carvalho, Marisa Pardal, Marta Afonso-Silva, Diana Grangeia, Ricardo Jorge Dinis-Oliveira, Francisco Araújo, Tiago Taveira-Gomes
Journal of Clinical Medicine.2022; 11(22): 6825. CrossRef
New and Emerging lipid-lowering Therapy
James M Backes, Daniel E Hilleman
Future Cardiology.2021; 17(8): 1407. CrossRef
Systemic PFOS and PFOA exposure and disturbed lipid homeostasis in humans: what do we know and what not?
Styliani Fragki, Hubert Dirven, Tony Fletcher, Bettina Grasl-Kraupp, Kristine Bjerve Gützkow, Ron Hoogenboom, Sander Kersten, Birgitte Lindeman, Jochem Louisse, Ad Peijnenburg, Aldert H. Piersma, Hans M. G. Princen, Maria Uhl, Joost Westerhout, Marco J. Z
Critical Reviews in Toxicology.2021; 51(2): 141. CrossRef
A network pharmacology analysis on drug‐like compounds from Ganoderma lucidum for alleviation of atherosclerosis
Ki Kwang Oh, Md. Adnan, Dong Ha Cho
Journal of Food Biochemistry.2021;[Epub] CrossRef
Efficacy and Safety of Fenofibrate-Statin Combination Therapy in Patients With Inadequately Controlled Triglyceride Levels Despite Previous Statin Monotherapy: A Multicenter, Randomized, Double-blind, Phase IV Study
Myung Soo Park, Jong-Chan Youn, Eung Ju Kim, Ki Hoon Han, Sang Hak Lee, Sung Hea Kim, Byung Jin Kim, Sung Uk Kwon, Kyu-Hyung Ryu
Clinical Therapeutics.2021; 43(10): 1735. CrossRef
Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany
Louis Jacob, Roger-Axel Greiner, Mark Luedde, Karel Kostev
Journal of Cardiovascular Pharmacology.2021; 78(6): 885. CrossRef
Challenging Issues in the Management of Cardiovascular Risk Factors in Diabetes During the COVID-19 Pandemic: A Review of Current Literature
Leili Rahimi, Mojtaba Malek, Faramarz Ismail-Beigi, Mohammad E. Khamseh
Advances in Therapy.2020; 37(8): 3450. CrossRef
Treatment With Gemfibrozil Prevents the Progression of Chronic Kidney Disease in Obese Dahl Salt-Sensitive Rats
Corbin A. Shields, Bibek Poudel, Kasi C. McPherson, Andrea K. Brown, Ubong S. Ekperikpe, Evan Browning, Lamari Sutton, Denise C. Cornelius, Jan M. Williams
Frontiers in Physiology.2020;[Epub] CrossRef
Oxidative Stress and Inflammation in Renal and Cardiovascular Complications of Diabetes
Amelia Charlton, Jessica Garzarella, Karin A. M. Jandeleit-Dahm, Jay C. Jha
Biology.2020; 10(1): 18. CrossRef

Original Articles

Cardiovascular Risk/Epidemiology
Pre-existing Depression among Newly Diagnosed Dyslipidemia Patients and Cardiovascular Disease Risk: Jihoon Andrew Kim, Seulggie Choi, Daein Choi, Sang Min Park; Diabetes Metab J. 2020;44(2):307-315. Published online November 1, 2019; DOI: https://doi.org/10.4093/dmj.2019.0002

9,288 View
110 Download
14 Web of Science
13 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background

Whether depression before diagnosis of dyslipidemia is associated with higher cardiovascular disease (CVD) risk among newly diagnosed dyslipidemia patients is yet unclear.

Methods

The study population consisted of 72,235 newly diagnosed dyslipidemia patients during 2003 to 2012 from the National Health Insurance Service–Health Screening Cohort of South Korea. Newly diagnosed dyslipidemia patients were then detected for pre-existing depression within 3 years before dyslipidemia diagnosis. Starting from 2 years after the diagnosis date, patients were followed up for CVD until 2015. Adjusted hazard ratios (aHRs) and 95% confidence intervals (CIs) for CVD were calculated by Cox proportional hazards regression.

Results

Compared to dyslipidemia patients without depression, those with depression had higher risk for CVD (aHR, 1.24; 95% CI, 1.09 to 1.41). Similarly, pre-existing depression was associated with increased risk for stroke (aHR, 1.27; 95% CI, 1.06 to 1.53). The risk for CVD among depressed dyslipidemia patients for high (aHR, 1.42; 95% CI, 1.06 to 1.90), medium (aHR, 1.17; 95% CI, 0.91 to 1.52), and low (aHR, 1.25; 95% CI, 1.05 to 1.50) statin compliance patients tended to be increased compared to patients without pre-existing dyslipidemia. The risk-elevating effect of depression on CVD tended to be preserved regardless of subgroups of smoking, alcohol consumption, physical activity, and body mass index.

Conclusion

Dyslipidemia patients with pre-existing depression had increased risk for CVD. Future studies that determine CVD risk after management of depression among dyslipidemia patients are needed.

Citations

Citations to this article as recorded by

Association of cholecystectomy with short-term and long-term risks of depression and suicide
Jiwon Yu, Sangwoo Park, Seogsong Jeong, Ahryoung Ko, Jaewon Lee, Saemi Han, Sang min Park
Scientific Reports.2025;[Epub] CrossRef
CHARLS insights into the impact of dual interactions of chronic diseases on depression in middle-aged and elderly individuals
Dian-yin Liang, Xue Chen, Ke-hua Li
Scientific Reports.2025;[Epub] CrossRef
An application of the Bayesian network model based on the EN-ESL-GA algorithm: Exploring the predictors of heart disease in middle-aged and elderly people in China
Wenlong Gao, Zhimei Zeng, Xiaojie Ma, Yongsong Ke, Minqian Zhi
Technology and Health Care.2024; 32(6): 3903. CrossRef
Higher atherogenic index of plasma is associated with increased major depressive disorder: insights from a nationally representative study
Shiyi Tao, Lintong Yu, Jun Li, Xuanchun Huang, Tiantian Xue, Deshuang Yang, Yuqing Tan
Frontiers in Psychiatry.2024;[Epub] CrossRef
Elevated remnant cholesterol and the risk of prevalent major depressive disorder: a nationwide population-based study
Shiyi Tao, Lintong Yu, Jun Li, Ji Wu, Deshuang Yang, Xuanchun Huang, Tiantian Xue
Frontiers in Psychiatry.2024;[Epub] CrossRef
Mediating effect of depression on the association between cardiovascular disease and the risk of all‐cause mortality: NHANES in 2005−2018
Xinxin Ma, Huan Zhang, Yuan Tian, Yaping Wang, Ling Liu, Lei Wang
Clinical Cardiology.2023; 46(11): 1380. CrossRef
Associations of sleep duration, daytime napping, and snoring with depression in rural China: a cross-sectional study
Xueyao Zhang, Guangxiao Li, Chuning Shi, Yingxian Sun
BMC Public Health.2023;[Epub] CrossRef
Association between socioeconomic inequality and the global prevalence of anxiety and depressive disorders: an ecological study
Fatemeh Shahbazi, Marjan Shahbazi, Jalal Poorolajal
General Psychiatry.2022; 35(3): e100735. CrossRef
Impact of Alexithymia on the Lipid Profile in Major Depressed Individuals
Camille Point, Benjamin Wacquier, Marjorie Dosogne, Mohammed Al Faker, Hadrien Willame, Gwenolé Loas, Matthieu Hein, Philip W. Wertz
Journal of Lipids.2022; 2022: 1. CrossRef
Association of Depression With Cardiovascular Diseases
Zain I Warriach, Sruti Patel, Fatima Khan, Gerardo F Ferrer
Cureus.2022;[Epub] CrossRef
Fenofibrate add-on to statin treatment is associated with low all-cause death and cardiovascular disease in the general population with high triglyceride levels
Kyung-Soo Kim, Sangmo Hong, Kyungdo Han, Cheol-Young Park
Metabolism.2022; 137: 155327. CrossRef
Dyslipidemia prevalence and trends among adult mental disorder inpatients in Beijing, 2005–2018: A longitudinal observational study
Fude Yang, Qiuyue Ma, Botao Ma, Wenzhan Jing, Jue Liu, Moning Guo, Juan Li, Zhiren Wang, Min Liu
Asian Journal of Psychiatry.2021; 57: 102583. CrossRef
Non-HDL cholesterol level and depression among Canadian elderly—a cross-sectional analysis of the baseline data from the CLSA
Jian Liu, Surim Son, Mike Giancaterino, Chris P. Verschoor, Miya Narushima, David Moher
FACETS.2020; 5(1): 1006. CrossRef

Epidemiology
Association between Change in Alcohol Consumption and Metabolic Syndrome: Analysis from the Health Examinees Study: Seulggie Choi, Kyuwoong Kim, Jong-Koo Lee, Ji-Yeob Choi, Aesun Shin, Sue Kyung Park, Daehee Kang, Sang Min Park; Diabetes Metab J. 2019;43(5):615-626. Published online April 23, 2019; DOI: https://doi.org/10.4093/dmj.2018.0128

10,518 View
124 Download
23 Web of Science
22 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background

The association between change in alcohol intake and metabolic syndrome is unclear.

Methods

This retrospective cohort consisted of 41,368 males and females from the Health Examinees-GEM study. Participants were divided into non-drinkers (0.0 g/day), light drinkers (male: 0.1 to 19.9 g/day; female: 0.1 to 9.9 g/day), moderate drinkers (male: 20.0 to 39.9 g/day; female: 10.0 to 19.9 g/day), and heavy drinkers (male: ≥40.0 g/day; female: ≥20.0 g/day) for each of the initial and follow-up health examinations. Logistic regression analysis was used to determine the adjusted odds ratios (aORs) and 95% confidence intervals (CIs) for developing metabolic syndrome according to the change in alcohol consumption between the initial and follow-up health examinations. Adjusted mean values for the change in waist circumference, fasting serum glucose (FSG), blood pressure, triglycerides, and high density lipoprotein cholesterol (HDL-C) levels were determined according to the change in alcohol consumption by linear regression analysis.

Results

Compared to persistent light drinkers, those who increased alcohol intake to heavy levels had elevated risk of metabolic syndrome (aOR, 1.45; 95% CI, 1.09 to 1.92). In contrast, heavy drinkers who became light drinkers had reduced risk of metabolic syndrome (aOR, 0.61; 95% CI, 0.44 to 0.84) compared to persistent heavy drinkers. Increased alcohol consumption was associated with elevated adjusted mean values for waist circumference, FSG, blood pressure, triglycerides, and HDL-C levels (all P<0.05). Reduction in alcohol intake was associated with decreased waist circumference, FSG, blood pressure, triglycerides, and HDL-C levels among initial heavy drinkers (all P<0.05).

Conclusion

Heavy drinkers who reduce alcohol consumption could benefit from reduced risk of metabolic syndrome.

Citations

Citations to this article as recorded by

The relationship between dietary inflammatory index and all-cause and cardiovascular disease-related mortality in adults with metabolic syndrome: a cohort study of NHANES
Qunwei Ma, Ying Zhang, Daowen Zhang, Cancan Liu, Weiwei Zhu, Guixia Wang, Nannan Xu, Xue Zhang, Rui Huang, Huijun Zhang, Shuhang Xu, Chao Liu, Kuanlu Fan
Frontiers in Endocrinology.2025;[Epub] CrossRef
Genetic Commonalities Between Metabolic Syndrome and Rheumatic Diseases Through Disease Interactome Modules
Yinli Shi, Shuang Guan, Xi Liu, Hongjun Zhai, Yingying Zhang, Jun Liu, Weibin Yang, Zhong Wang
Journal of Cellular and Molecular Medicine.2025;[Epub] CrossRef
Association between Mediterranean diet and metabolic syndrome: analysis of NHANES 2007–2020
Qile Kang, Xuejiao Mei, Chiwei Guo, Yifan Si, Nongrong Wang
International Journal of Food Sciences and Nutrition.2025; 76(2): 209. CrossRef
2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association
Seth S. Martin, Aaron W. Aday, Norrina B. Allen, Zaid I. Almarzooq, Cheryl A.M. Anderson, Pankaj Arora, Christy L. Avery, Carissa M. Baker-Smith, Nisha Bansal, Andrea Z. Beaton, Yvonne Commodore-Mensah, Maria E. Currie, Mitchell S.V. Elkind, Wenjun Fan, G
Circulation.2025;[Epub] CrossRef
Long‐term alcohol consumption and incident health risk conditions related to cardiometabolic risk markers: A 20‐year prospective cohort study
Sooyeun Choi, Taeyoung Park, Youjin Je
Addiction.2025; 120(9): 1840. CrossRef
Associations Between Shift Work and Insulin Resistance Markers in 53,053 Spanish Workers: A Sex-Stratified Cross-Sectional Analysis Using TyG, TyG-BMI, METS-IR, and SPISE-IR Indices
Javier Tosoratto, Pedro Juan Tárraga López, Ángel Arturo López-González, Carla Busquets-Cortes, Joan Obrador de Hevia, José Ignacio Ramirez-Manent
Journal of Clinical Medicine.2025; 14(13): 4604. CrossRef
The Interplay Between Alcohol Consumption and Cardiometabolic Risk Factors in Individuals With MASLD and MetALD
Yee Hui Yeo, Fajuan Rui, Yixuan Zhu, Xiaoming Xu, Xiaoyan Ma, Wenjing Ni, Yuxiang Sun, Xinyu Hu, Chao Wu, Junping Shi, Jie Li, Philip N. Newsome
Portal Hypertension & Cirrhosis.2025; 4(3): 157. CrossRef
Association of the dietary index for gut microbiota with metabolic syndrome and its components combining interpretable machine learning algorithms
Yu Cai, Sheng-Jia Wang, Yan-Yan Tan, De-Liang Liu, Shu-Fang Chu, Hui-Lin Li
Journal of Health, Population and Nutrition.2025;[Epub] CrossRef
Inverse association between type 2 diabetes and hepatocellular carcinoma in East Asian populations
Jinlong Huo, Yaxuan Xu, Xingqi Chen, Jie Yu, Lijin Zhao
Frontiers in Endocrinology.2024;[Epub] CrossRef
Regulation Mechanism and Potential Value of Active Substances in Spices in Alcohol–Liver–Intestine Axis Health
Jianyu Huang, Tao Huang, Jinjun Li
International Journal of Molecular Sciences.2024; 25(7): 3728. CrossRef
Impact of green space and built environment on metabolic syndrome: A systematic review with meta-analysis
Muhammad Mainuddin Patwary, Mohammad Javad Zare Sakhvidi, Sadia Ashraf, Payam Dadvand, Matthew H.E.M. Browning, Md Ashraful Alam, Michelle L. Bell, Peter James, Thomas Astell-Burt
Science of The Total Environment.2024; 923: 170977. CrossRef
Causal effects of sleep traits on metabolic syndrome and its components: a Mendelian randomization study
Yongli Yang, Long Wen, Xuezhong Shi, Chaojun Yang, Jingwen Fan, Yi Zhang, Guibin Shen, Huiping Zhou, Xiaocan Jia
Sleep and Breathing.2024; 28(3): 1423. CrossRef
Association of lifestyle trajectory and total lifestyle change score with risk of metabolic syndrome: The prospective community-based Ansung-Ansan cohort study
Jialei Fu, Sangah Shin
Clinical Nutrition.2024; 43(12): 109. CrossRef
Use of biochemical markers for diabetes prevention in the new decade
Marie Chan Sun, Marie A. S. Landinaff, Ruben Thoplan
Physical Sciences Reviews.2023; 8(11): 3767. CrossRef
Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, Ville Männistö, Silvia Sookoian
Journal of Hepatology.2023; 78(1): 191. CrossRef
Serum Nutritional Biomarkers and All-Cause and Cause-Specific Mortality in U.S. Adults with Metabolic Syndrome: The Results from National Health and Nutrition Examination Survey 2001–2006
Xinwei Peng, Jingjing Zhu, Henry S. Lynn, Xi Zhang
Nutrients.2023; 15(3): 553. CrossRef
Evaluation and Treatment of Obesity and Its Comorbidities: 2022 Update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity
Kyoung-Kon Kim, Ji-Hee Haam, Bom Taeck Kim, Eun Mi Kim, Jung Hwan Park, Sang Youl Rhee, Eonju Jeon, Eungu Kang, Ga Eun Nam, Hye Yeon Koo, Jeong-Hyun Lim, Jo-Eun Jeong, Jong-Hee Kim, Jong Won Kim, Jung Ha Park, Jun Hwa Hong, Sang Eok Lee, Se Hee Min, Seung
Journal of Obesity & Metabolic Syndrome.2023; 32(1): 1. CrossRef
Association between alcohol consumption and risk of hyperuricaemia among adults: a large cross-sectional study in Chongqing, China
Siyu Chen, Rui Ding, Xiaojun Tang, Liling Chen, Qinwen Luo, Meng Xiao, Xianbin Ding, Bin Peng
BMJ Open.2023; 13(12): e074697. CrossRef
Lifestyle Factors Associated with Metabolic Syndrome in Urban Cambodia
Miharu Tamaoki, Ikumi Honda, Keisuke Nakanishi, Maki Nakajima, Sophathya Cheam, Manabu Okawada, Hisataka Sakakibara
International Journal of Environmental Research and Public Health.2022; 19(17): 10481. CrossRef
Gender Differences of Health Behaviors in the Risk of Metabolic Syndrome for Middle-Aged Adults: A National Cross-Sectional Study in South Korea
Jaehee Yoon, Jeewuan Kim, Heesook Son
International Journal of Environmental Research and Public Health.2021; 18(7): 3699. CrossRef
Association between alcohol consumption and metabolic syndrome among Chinese adults
Yi Lin, Yan-Yan Ying, Si-Xuan Li, Si-Jia Wang, Qing-Hai Gong, Hui Li
Public Health Nutrition.2021; 24(14): 4582. CrossRef
Triglyceride-rich lipoprotein and LDL particle subfractions and their association with incident type 2 diabetes: the PREVEND study
Sara Sokooti, Jose L. Flores-Guerrero, Hiddo J. L. Heerspink, Margery A. Connelly, Stephan J. L. Bakker, Robin P. F. Dullaart
Cardiovascular Diabetology.2021;[Epub] CrossRef

Others
Effect of Atorvastatin on Growth Differentiation Factor-15 in Patients with Type 2 Diabetes Mellitus and Dyslipidemia: Ji Min Kim, Min Kyung Back, Hyon-Seung Yi, Kyong Hye Joung, Hyun Jin Kim, Bon Jeong Ku; Diabetes Metab J. 2016;40(1):70-78. Published online February 19, 2016; DOI: https://doi.org/10.4093/dmj.2016.40.1.70

7,165 View
51 Download
5 Web of Science
5 Crossref

Abstract PDF PubReader ePub

Background

Elevated serum levels of growth differentiation factor-15 (GDF-15) are associated with type 2 diabetes. Therefore, the effects of atorvastatin on metabolic parameters and GDF-15 levels in patients with type 2 diabetes and dyslipidemia were evaluated.

Methods

In this prospective randomized trial from February 2013 to March 2014, 50 consecutive type 2 diabetic patients with a low density lipoprotein cholesterol (LDL-C) levels ≥100 mg/dL were enrolled. The patients were divided into two groups based on the amount of atorvastatin prescribed, 10 mg/day (n=23) or 40 mg/day (n=27). The effect of atorvastatin on metabolic parameters, including lipid profiles and GDF-15 levels, at baseline and after 8 weeks of treatment were compared.

Results

The baseline metabolic parameters and GDF-15 levels were not significantly different between the two groups. After 8 weeks of treatment, the total cholesterol (TC) and LDL-C levels were significantly decreased in both groups. The mean changes in TC and LDL-C levels were more significant in the 40 mg atorvastatin group. The GDF-15 level was decreased in the 10 mg atorvastatin group, from 1,460.6±874.8 to 1,451.0±770.8 pg/mL, and was increased in the 40 mg atorvastatin group, from 1,271.6±801.0 to 1,341.4±855.2 pg/mL. However, the change in the GDF-15 level was not statistically significant in the 10 or 40 mg atorvastatin group (P=0.665 and P=0.745, respectively).

Conclusion

The GDF-15 levels were not significantly changed after an 8-week treatment with atorvastatin in type 2 diabetic patients.

Citations

Citations to this article as recorded by

The relationship of Growth differentiation factor-15 with renal damage and dyslipidemia in non-albuminuric and albuminuric Type-2 Diabetes Mellitus
Hasan Esat Yücel, Bilal İlanbey
Medical Science and Discovery.2022; 9(6): 334. CrossRef
Comparative effectiveness of statins on non-high density lipoprotein cholesterol in people with diabetes and at risk of cardiovascular disease: systematic review and network meta-analysis
Alexander Hodkinson, Dialechti Tsimpida, Evangelos Kontopantelis, Martin K Rutter, Mamas A Mamas, Maria Panagioti
BMJ.2022; 376: e067731. CrossRef
The Cytokine Growth Differentiation Factor-15 and Skeletal Muscle Health: Portrait of an Emerging Widely Applicable Disease Biomarker
Boel De Paepe
International Journal of Molecular Sciences.2022; 23(21): 13180. CrossRef
Biomarkers of subclinical atherosclerosis in patients with psoriasis
Hannah Kaiser, Xing Wang, Amanda Kvist-Hansen, Martin Krakauer, Peter Michael Gørtz, Benjamin D. McCauley, Lone Skov, Christine Becker, Peter Riis Hansen
Scientific Reports.2021;[Epub] CrossRef
Growth differentiation factor-15 regulates oxLDL-induced lipid homeostasis and autophagy in human macrophages
Kathrin Ackermann, Gabriel A. Bonaterra, Ralf Kinscherf, Anja Schwarz
Atherosclerosis.2019; 281: 128. CrossRef

First
Prev
Page of 1
Next
Last

Search